TWI710585B - Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element Download PDF

Info

Publication number
TWI710585B
TWI710585B TW106122049A TW106122049A TWI710585B TW I710585 B TWI710585 B TW I710585B TW 106122049 A TW106122049 A TW 106122049A TW 106122049 A TW106122049 A TW 106122049A TW I710585 B TWI710585 B TW I710585B
Authority
TW
Taiwan
Prior art keywords
liquid crystal
crystal alignment
mol
alignment agent
compound
Prior art date
Application number
TW106122049A
Other languages
Chinese (zh)
Other versions
TW201905039A (en
Inventor
王建智
Original Assignee
奇美實業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇美實業股份有限公司 filed Critical 奇美實業股份有限公司
Priority to TW106122049A priority Critical patent/TWI710585B/en
Priority to CN201810683322.9A priority patent/CN109207170B/en
Publication of TW201905039A publication Critical patent/TW201905039A/en
Application granted granted Critical
Publication of TWI710585B publication Critical patent/TWI710585B/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1067Wholly aromatic polyimides, i.e. having both tetracarboxylic and diamino moieties aromatically bound
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2379/00Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen, or carbon only, not provided for in groups C08J2361/00 - C08J2377/00
    • C08J2379/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08J2379/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors

Abstract

The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element. The liquid crystal alignment agent includes a polymer (A) and a solvent (B). The polymer (A) is synthesized by a tetracarboxylic dianhydride compound (a) and a diamine compound (b). The aforementioned liquid crystal alignment agent has a specific viscosity, so as to fabricate the liquid crystal alignment film with high Young's Modulus and the liquid crystal display element including the liquid crystal alignment film. There are no defects of Particle-Galaxy in the liquid crystal display element.

Description

液晶配向劑、液晶配向膜及液晶顯示元件 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

本發明係有關一種液晶配向劑、液晶配向膜及液晶顯示元件,特別是提供一種具有特定黏度之液晶配向劑,及其所形成具有高楊氏模量的液晶配向膜,以及具有該液晶配向膜之液晶顯示元件。 The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element, and particularly provides a liquid crystal alignment agent with a specific viscosity, and a liquid crystal alignment film with high Young's modulus formed thereon, and the liquid crystal alignment film The liquid crystal display element.

近年來,新的液晶顯示元件之開發蓬勃發展,其中,例如業界開發出一種液晶顯示元件,其藉由單側基板上以櫛齒狀方式配置兩個電極來驅動液晶,使基板表面產生平行電場,以控制液晶分子。上述液晶顯示元件一般被稱為橫向電場效應型(IPS型),已知其具有出色的廣視角特性。然而,上述IPS型液晶顯示元件仍有因離子密度過高而產生殘影之問題。 In recent years, the development of new liquid crystal display elements has been vigorously developed. For example, the industry has developed a liquid crystal display element that drives the liquid crystal by arranging two electrodes on a single-sided substrate in a comb-tooth manner to generate a parallel electric field on the surface of the substrate. , To control the liquid crystal molecules. The above-mentioned liquid crystal display element is generally called a lateral electric field effect type (IPS type), and it is known that it has excellent wide viewing angle characteristics. However, the aforementioned IPS type liquid crystal display element still has the problem of image retention due to excessively high ion density.

日本專利特開第2009-175684號公報揭示一種低離子密度的液晶配向膜及一種用以製備液晶配向膜的含哌嗪(piperazine)結構之二胺化合物。透過使用含哌嗪結 構之二胺化合物,所製得之配向膜可改善離子密度過高之問題。 Japanese Patent Laid-Open No. 2009-175684 discloses a low ion density liquid crystal alignment film and a piperazine structure-containing diamine compound for preparing the liquid crystal alignment film. By using a diamine compound containing a piperazine structure, the resulting alignment film can improve the problem of excessive ion density.

然而,上述液晶配向劑所製得液晶配向膜之楊氏模量(Young's Modulus)過低,當其應用於液晶顯示元件時,所製得之液晶顯示元件易有大量碎亮點產生之缺陷,而降低其顯示品質。 However, the Young's Modulus of the liquid crystal alignment film prepared by the above liquid crystal alignment agent is too low. When it is applied to a liquid crystal display device, the liquid crystal display device prepared is prone to defects caused by a large number of broken bright spots. Reduce its display quality.

由上述可知,為了符合目前IPS型液晶顯示器業者之要求,如何提高液晶配向膜之楊氏模量,以消除碎亮點缺陷之液晶顯示元件為本技術領域者努力研究之目標。 It can be seen from the above that in order to meet the requirements of the current IPS type liquid crystal display industry, how to improve the Young's modulus of the liquid crystal alignment film to eliminate the liquid crystal display element with broken bright spots is the goal of the technical field.

因此,本發明之一態樣是在提供一種液晶配向劑。此液晶配向劑包含聚合物(A)及溶劑(B)。 Therefore, one aspect of the present invention is to provide a liquid crystal alignment agent. The liquid crystal alignment agent includes a polymer (A) and a solvent (B).

本發明之另一態樣是在提供一種液晶配向膜,其包含上述之液晶配向劑。 Another aspect of the present invention is to provide a liquid crystal alignment film comprising the above-mentioned liquid crystal alignment agent.

本發明之又一態樣是在提供一種液晶顯示元件,其具有上述之液晶配向膜,且此液晶顯示元件沒有碎亮點產生之缺陷。 Another aspect of the present invention is to provide a liquid crystal display element having the above-mentioned liquid crystal alignment film, and the liquid crystal display element has no defects caused by broken bright spots.

根據本發明之上述態樣,提出一種液晶配向劑。此液晶配向劑包含聚合物(A)及溶劑(B),以下析述之。 According to the above aspect of the present invention, a liquid crystal alignment agent is proposed. The liquid crystal alignment agent includes polymer (A) and solvent (B), which will be analyzed below.

聚合物(A)Polymer (A)

本發明之聚合物(A)由四羧酸二酐化合物(a)與二胺化合物(b)反應而得。 The polymer (A) of the present invention is obtained by reacting a tetracarboxylic dianhydride compound (a) with a diamine compound (b).

上述聚合物(A)之較佳具體例為聚醯胺酸聚合物、聚醯亞胺聚合物、聚醯亞胺系嵌段共聚合物,或此等一組合。其中,聚醯亞胺系嵌段共聚合物之較佳具體例為聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物,或其中之一組合。 Preferable specific examples of the above-mentioned polymer (A) are polyimide polymers, polyimide polymers, polyimine-based block copolymers, or a combination of these. Among them, preferred specific examples of polyimide block copolymers are polyimide block copolymers, polyimide block copolymers, polyimide-polyimide block copolymers, and polyimide block copolymers. Polymer, or a combination of them.

四羧酸二酐化合物(a)Tetracarboxylic dianhydride compound (a)

本發明之四羧酸二酐化合物(a)可包含如下式(I)所示之四羧酸二酐化合物(a-1)。其次,該四羧酸二酐化合物(a)可選擇性地包含其他四羧酸二酐化合物(a-2)。 The tetracarboxylic dianhydride compound (a) of the present invention may include the tetracarboxylic dianhydride compound (a-1) represented by the following formula (I). Second, the tetracarboxylic dianhydride compound (a) may optionally contain other tetracarboxylic dianhydride compounds (a-2).

四羧酸二酐化合物(a-1)Tetracarboxylic dianhydride compound (a-1)

該四羧酸二酐化合物(a-1)具有如式(I)所示之結構:

Figure 106122049-A0101-12-0003-1
The tetracarboxylic dianhydride compound (a-1) has a structure as shown in formula (I):
Figure 106122049-A0101-12-0003-1

於式(I)中,R1、R2、R3、R4、R5及R6分別獨立地選自於由鹵素原子、經取代或不取代之烷基、經取代或不取代之烷氧基及經取代或不取代之芳香基所組成之一族群的至少一種;Z分別獨立地代表-CONH-、-NHCO-、-NHCO2-、-OCONH-或-NHCONH-;h、i、j及k分別獨立地代表0至4之整數;m及n分別獨立地代表0至3之整數。 In the formula (I), R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently selected from halogen atoms, substituted or unsubstituted alkyl groups, and substituted or unsubstituted alkyl groups. At least one of a group consisting of an oxy group and a substituted or unsubstituted aromatic group; Z each independently represents -CONH-, -NHCO-, -NHCO 2 -, -OCONH- or -NHCONH-; h, i, j and k each independently represent an integer from 0 to 4; m and n each independently represent an integer from 0 to 3.

前述之鹵素原子可為氟原子、氯原子、溴原子或碘原子等。較佳地,該鹵素原子可為氟原子,氯原子或溴原子。該經取代或不取代之烷基可為甲基、乙基、丙基、異丙基或三氟甲基等碳數為1至8之烷基。較佳地,該經取代或不取代之烷基可為甲基、三氟甲基或異丙基。該經取代或不取代之烷氧基可為甲氧基、乙氧基或苯氧基等碳數為1至8之烷氧基。較佳地,該經取代或不取代之烷氧基可為甲氧基或苯氧基。該經取代或不取代之芳香基可為苯基、萘基或對-甲氧基苯基等碳數為6至14之單環或縮合多環芳香族。較佳地,該經取代或不取代之芳香基可為苯基。較佳地,該Z可為-CONH-或-NHCO-。 The aforementioned halogen atom may be a fluorine atom, a chlorine atom, a bromine atom or an iodine atom. Preferably, the halogen atom may be a fluorine atom, a chlorine atom or a bromine atom. The substituted or unsubstituted alkyl group may be an alkyl group having 1 to 8 carbon atoms, such as methyl, ethyl, propyl, isopropyl or trifluoromethyl. Preferably, the substituted or unsubstituted alkyl group may be methyl, trifluoromethyl or isopropyl. The substituted or unsubstituted alkoxy group may be an alkoxy group having 1 to 8 carbon atoms such as methoxy, ethoxy or phenoxy. Preferably, the substituted or unsubstituted alkoxy group may be a methoxy group or a phenoxy group. The substituted or unsubstituted aromatic group may be a monocyclic or condensed polycyclic aromatic having a carbon number of 6 to 14 such as phenyl, naphthyl or p-methoxyphenyl. Preferably, the substituted or unsubstituted aromatic group may be a phenyl group. Preferably, the Z can be -CONH- or -NHCO-.

前述之m及n較佳可分別獨立地代表0至2之整數,前述之h、i、j及k較佳可分別獨立地代表0至2之整數。 The foregoing m and n preferably each independently represent an integer from 0 to 2, and the foregoing h, i, j, and k preferably each independently represent an integer from 0 to 2.

在一實施例中,該四羧酸二酐化合物(a-1)可包含如下式(I-1)至式(I-8)所示之四羧酸二酐化合物。 In an embodiment, the tetracarboxylic dianhydride compound (a-1) may include the tetracarboxylic dianhydride compound represented by the following formula (I-1) to formula (I-8).

Figure 106122049-A0101-12-0004-2
Figure 106122049-A0101-12-0004-2

Figure 106122049-A0101-12-0005-3
Figure 106122049-A0101-12-0005-3

Figure 106122049-A0101-12-0005-4
Figure 106122049-A0101-12-0005-4

Figure 106122049-A0101-12-0005-5
Figure 106122049-A0101-12-0005-5

Figure 106122049-A0101-12-0005-6
Figure 106122049-A0101-12-0005-6

Figure 106122049-A0101-12-0006-8
Figure 106122049-A0101-12-0006-8

Figure 106122049-A0101-12-0006-10
Figure 106122049-A0101-12-0006-10

Figure 106122049-A0101-12-0006-11
Figure 106122049-A0101-12-0006-11

前述之四羧酸二酐化合物(a-1)可單獨一種使用或混合複數種使用。 The aforementioned tetracarboxylic dianhydride compound (a-1) may be used singly or in combination of plural kinds.

基於四羧酸二酐化合物(a)之總使用量為100莫耳,四羧酸二酐化合物(a-1)之使用量為5莫耳至60莫耳,較佳為10莫耳至55莫耳,且更佳為15莫耳至50莫耳。 Based on the total usage amount of the tetracarboxylic dianhydride compound (a) is 100 mol, the usage amount of the tetracarboxylic dianhydride compound (a-1) is 5 mol to 60 mol, preferably 10 mol to 55 Mol, and more preferably 15 mol to 50 mol.

若液晶配向劑之四羧酸二酐化合物(a)不包含四羧酸二酐化合物(a-1)時,所製得之液晶配向膜的楊氏模量過低,無法改善液晶顯示元件之碎亮點缺陷,而難以提升顯示品質。 If the tetracarboxylic dianhydride compound (a) of the liquid crystal alignment agent does not contain the tetracarboxylic dianhydride compound (a-1), the Young's modulus of the resulting liquid crystal alignment film is too low, and the performance of the liquid crystal display element cannot be improved. It is difficult to improve the display quality due to broken bright spots.

其中,當如式(I)所示之四羧酸二酐化合物(a-1)中的Z代表-CONH-或-NHCO-時,所製得之液晶配向膜具有較高楊氏模量,而可進一步改善液晶顯示元件之碎亮點缺陷。 Wherein, when Z in the tetracarboxylic dianhydride compound (a-1) represented by formula (I) represents -CONH- or -NHCO-, the resulting liquid crystal alignment film has a higher Young's modulus, It can further improve the defect of broken bright spots of liquid crystal display elements.

其他四羧酸二酐化合物(a-2)Other tetracarboxylic dianhydride compounds (a-2)

除前述之四羧酸二酐化合物(a-1)以外,在不影響功效的範圍內,本發明的四羧酸二酐化合物(a)亦可選擇性地包含其他四羧酸二酐化合物(a-2)。 In addition to the aforementioned tetracarboxylic dianhydride compound (a-1), the tetracarboxylic dianhydride compound (a) of the present invention may optionally contain other tetracarboxylic dianhydride compounds ( a-2).

其他四羧酸二酐化合物(a-2)之較佳具體例為(1)脂肪族四羧酸二酐化合物、(2)脂環族四羧酸二酐化合物、(3)芳香族四羧酸二酐化合物或(4)具有如式(IV-1)至(IV-6)所示之結構的四羧酸二酐化合物等。 Preferred specific examples of other tetracarboxylic dianhydride compounds (a-2) are (1) aliphatic tetracarboxylic dianhydride compound, (2) alicyclic tetracarboxylic dianhydride compound, (3) aromatic tetracarboxylic acid An acid dianhydride compound or (4) a tetracarboxylic dianhydride compound having the structure shown in formula (IV-1) to (IV-6), etc.

本發明之(1)脂肪族四羧酸二酐化合物可包含但不限於乙烷四羧酸二酐或丁烷四羧酸二酐等之脂肪族四羧酸二酐化合物。 The (1) aliphatic tetracarboxylic dianhydride compound of the present invention may include, but is not limited to, aliphatic tetracarboxylic dianhydride compounds such as ethane tetracarboxylic dianhydride or butane tetracarboxylic dianhydride.

本發明之(2)脂環族四羧酸二酐化合物可包含但不限於1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3',4,4'-二環己基四羧酸二酐、順-3,7-二丁基環庚基-1,5-二烯-1,2,5,6-四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐或二環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐等之脂環族四羧酸二酐化合物。 The (2) alicyclic tetracarboxylic dianhydride compound of the present invention can include but is not limited to 1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2-dimethyl-1,2,3 ,4-Cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dichloro-1,2,3, 4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopenta Alkyltetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, cis-3,7-di Butylcycloheptyl-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride or bicyclo[2.2.2]- Alicyclic tetracarboxylic dianhydride compounds such as oct-7-ene-2,3,5,6-tetracarboxylic dianhydride.

本發明之(3)芳香族四羧酸二酐化合物之具體例可包含但不限於3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐、2,2',3,3'-二苯甲酮四羧酸二酐、3,3',4,4'-二苯甲酮四羧酸二酐、3,3',4,4'-聯苯碸四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3'-4,4'-二苯基乙烷四羧酸二酐、3,3',4,4'-二甲基二苯基矽烷四羧酸二酐、3,3',4,4'-四苯基矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、2,3,3',4'-二苯醚四羧酸二酐、3,3',4,4'-二苯醚四羧酸二酐、4,4'-雙(3,4-二羧基苯氧基)二苯硫醚二酐、2,3,3',4'-二苯硫醚四羧酸二酐、3,3',4,4'-二苯硫醚四羧酸二酐、4,4'-雙(3,4-二羧基苯氧基)二苯碸二酐、、4,4'-雙(3,4-二羧基苯氧基)二苯丙烷二酐、3,3',4,4'-全氟異亞丙基二苯二酸二酐、2,2',3,3'-二苯基四羧酸二酐、2,3,3',4'-二苯基四羧酸二酐、3,3',4,4'-二苯基四羧酸二酐、雙(苯二酸)苯膦氧化物二酐、對-伸苯基-雙(三苯基苯二酸)二酐、間-伸苯基-雙(三苯基苯二酸)二酐、雙(三苯基苯二酸)-4,4'-二苯基醚二酐、雙(三苯基苯二酸)-4,4'-二苯基甲烷二酐、乙二醇-雙(脫水偏苯三酸酯)、丙二醇-雙(脫水偏苯三酸酯)、1,4-丁二醇-雙(脫水偏苯三酸酯)、1,6-己二醇-雙(脫水偏苯三酸酯)、1,8-辛二醇-雙(脫水偏苯三酸酯)、2,2-雙(4-羥苯基)丙烷-雙(脫水偏苯三酸酯)、2,3,4,5-四氫呋喃四羧酸二酐、1,3,3a,4,5,9b-六氫-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-甲基-5-(四氫-2,5-二側 氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5,8-二甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、5-(2,5-二側氧基四氫呋喃基)-3-甲基-3-環己烯-1,2-二羧酸二酐等。 Specific examples of the (3) aromatic tetracarboxylic dianhydride compound of the present invention may include, but are not limited to, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, benzene Tetracarboxylic dianhydride, 2,2',3,3'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 3,3' ,4,4'-Biphenyltetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3'- 4,4'-Diphenylethane tetracarboxylic dianhydride, 3,3',4,4'-Dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3',4,4'-tetra Phenylsilane tetracarboxylic dianhydride, 1,2,3,4-furan tetracarboxylic dianhydride, 2,3,3',4'-diphenyl ether tetracarboxylic dianhydride, 3,3',4, 4'-diphenyl ether tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy) diphenyl sulfide dianhydride, 2,3,3',4'-diphenyl sulfide Tetracarboxylic dianhydride, 3,3',4,4'-diphenyl sulfide tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy) diphenyl dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3,3',4,4'-perfluoroisopropylidene diphthalic dianhydride, 2,2' ,3,3'-Diphenyltetracarboxylic dianhydride, 2,3,3',4'-Diphenyltetracarboxylic dianhydride, 3,3',4,4'-Diphenyltetracarboxylic acid Dianhydride, bis(phthalic acid) phenylphosphine oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride, m-phenylene-bis(triphenylphthalic acid) bis Anhydride, bis(triphenylphthalic acid)-4,4'-diphenyl ether dianhydride, bis(triphenylphthalic acid)-4,4'-diphenylmethane dianhydride, ethylene glycol- Bis (anhydro trimellitate), propylene glycol-bis (anhydro trimellitate), 1,4-butanediol-bis (anhydro trimellitate), 1,6-hexanediol-bis ( Dehydrated trimellitate), 1,8-octanediol-bis(dehydrated trimellitate), 2,2-bis(4-hydroxyphenyl)propane-bis(dehydrated trimellitate), 2,3,4,5-Tetrahydrofurantetracarboxylic dianhydride, 1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-diside oxy-3-furanyl) -Naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-methyl-5-(tetrahydro-2,5- (Di-side oxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-ethyl- 5-(Tetrahydro-2,5-diside oxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5, 9b-hexahydro-7-methyl-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-ethyl-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c] -Furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxy-3-furanyl) -Naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-ethyl-5-(tetrahydro-2,5- Di-side oxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5,8-di Methyl-5-(tetrahydro-2,5-diside oxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 5-(2,5- Di-side oxytetrahydrofuranyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride and the like.

本發明之(4)具有如式(IV-1)至(IV-6)所示之結構的四羧酸二酐化合物分別如下所示。 The (4) tetracarboxylic dianhydride compounds having the structures shown in formulas (IV-1) to (IV-6) of the present invention are as follows, respectively.

Figure 106122049-A0101-12-0009-12
Figure 106122049-A0101-12-0009-12

Figure 106122049-A0101-12-0010-13
Figure 106122049-A0101-12-0010-13

Figure 106122049-A0101-12-0010-14
Figure 106122049-A0101-12-0010-14

Figure 106122049-A0101-12-0010-15
Figure 106122049-A0101-12-0010-15

Figure 106122049-A0101-12-0011-16
Figure 106122049-A0101-12-0011-16

於式(IV-5)中,X1代表具有芳香環的二價基團,X2及X3可為相同或不同,且X2及X3可分別獨立地代表氫原子或烷基,且r代表1至2的整數。該具有如式(IV-5)所示之結構的的四羧酸二酐化合物較佳為具有如下式(IV-5-1)至式(IV-5-3)所示之結構的化合物。 In formula (IV-5), X 1 represents a divalent group having an aromatic ring, X 2 and X 3 may be the same or different, and X 2 and X 3 may each independently represent a hydrogen atom or an alkyl group, and r represents an integer from 1 to 2. The tetracarboxylic dianhydride compound having the structure shown in formula (IV-5) is preferably a compound having the structure shown in the following formulas (IV-5-1) to (IV-5-3).

Figure 106122049-A0101-12-0011-17
Figure 106122049-A0101-12-0011-17

Figure 106122049-A0101-12-0011-18
Figure 106122049-A0101-12-0011-18

Figure 106122049-A0101-12-0011-19
Figure 106122049-A0101-12-0011-19

Figure 106122049-A0101-12-0012-20
Figure 106122049-A0101-12-0012-20

於式(IV-6)中,X4代表具有芳香環的二價基團,X5及X6可為相同或不同,且X5及X6可分別獨立地代表氫原子或烷基。該具有如式(IV-6)所示之結構的四羧酸二酐化合物較佳為具有如下式(IV-6-1)所示之結構的化合物。 In formula (IV-6), X 4 represents a divalent group having an aromatic ring, X 5 and X 6 may be the same or different, and X 5 and X 6 may each independently represent a hydrogen atom or an alkyl group. The tetracarboxylic dianhydride compound having the structure shown in formula (IV-6) is preferably a compound having the structure shown in the following formula (IV-6-1).

Figure 106122049-A0101-12-0012-21
Figure 106122049-A0101-12-0012-21

較佳地,該四羧酸二酐化合物(a-2)可包含但不限於1,2,3,4-環丁烷四羧酸二酐(1,2,3,4-cyclobutane tetracarboxylic acid dianhydride)、1,2,3,4-環戊烷四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐(2,3,5-tri carboxycyclopentylacetic acid dianhydride)、1,2,4,5-環己烷四羧酸二酐、3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐(pyromellitic dianhydride)、3,3',4,4'-二苯甲酮四羧酸二酐或3,3',4,4'-聯苯碸四羧酸二酐等。前述之四羧酸二酐化合物(a-2)可單獨一種使用或者混合複數種使用。 Preferably, the tetracarboxylic dianhydride compound (a-2) may include, but is not limited to, 1,2,3,4-cyclobutane tetracarboxylic acid dianhydride (1,2,3,4-cyclobutane tetracarboxylic acid dianhydride) ), 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 2,3,5-tri carboxycyclopentylacetic acid dianhydride (2,3,5-tri carboxycyclopentylacetic acid dianhydride), 1,2, 4,5-Cyclohexanetetracarboxylic dianhydride, 3,4-Dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride , 3,3',4,4'-benzophenone tetracarboxylic dianhydride or 3,3',4,4'-biphenyl tetracarboxylic dianhydride, etc. The aforementioned tetracarboxylic dianhydride compound (a-2) may be used singly or in combination of plural kinds.

基於二胺化合物(b)之總使用量為100莫耳,四羧酸二酐化合物(a)之使用量為20莫耳至200莫耳,且較佳為30莫耳至120莫耳。 Based on the total usage amount of the diamine compound (b) being 100 mol, the usage amount of the tetracarboxylic dianhydride compound (a) is 20 mol to 200 mol, and preferably 30 mol to 120 mol.

二胺化合物(b)Diamine compound (b)

本發明之二胺化合物(b)包含如下式(II)所示之二胺化合物(b-1)及/或如下式(III)所示之二胺化合物(b-2)。其次,該二胺化合物(b)可選擇性地包含其他二胺化合物(b-3)。 The diamine compound (b) of the present invention includes a diamine compound (b-1) represented by the following formula (II) and/or a diamine compound (b-2) represented by the following formula (III). Second, the diamine compound (b) may optionally contain other diamine compounds (b-3).

二胺化合物(b-1)Diamine compound (b-1)

該二胺化合物(b-1)具有如下式(II)所示之結構:

Figure 106122049-A0101-12-0013-22
The diamine compound (b-1) has a structure represented by the following formula (II):
Figure 106122049-A0101-12-0013-22

於式(II)中,W1代表被3級氮原子所取代且碳數為4至6之伸環烷基,且W2代表碳數為1至5之伸烷基。 In the formula (II), W 1 represents a cycloalkylene group with a carbon number of 4 to 6 substituted by a tertiary nitrogen atom, and W 2 represents an alkylene group with a carbon number of 1 to 5.

其中,該3級氮原子係指氮原子之3個鍵結與氫原子以外之原子鍵結。較佳地,該3級氮原子代表與碳原子鍵結之氮原子。 Among them, the tertiary nitrogen atom refers to the three bonds of nitrogen atoms that are bonded to atoms other than hydrogen atoms. Preferably, the tertiary nitrogen atom represents a nitrogen atom bonded to a carbon atom.

較佳地,於式(II)中,該W1代表

Figure 106122049-A0101-12-0013-23
Figure 106122049-A0101-12-0013-24
,且W2代表碳數為1至5之伸烷基。 Preferably, in formula (II), the W 1 represents
Figure 106122049-A0101-12-0013-23
or
Figure 106122049-A0101-12-0013-24
, And W 2 represents an alkylene group having a carbon number of 1 to 5.

在一具體例中,如式(II)所示之二胺化合物(b-1)具有如下式(II-1)至式(II-5)所示之結構的二胺化合物:

Figure 106122049-A0101-12-0014-25
In a specific example, the diamine compound (b-1) represented by the formula (II) has a diamine compound having the structure represented by the following formula (II-1) to formula (II-5):
Figure 106122049-A0101-12-0014-25

Figure 106122049-A0101-12-0014-26
Figure 106122049-A0101-12-0014-26

Figure 106122049-A0101-12-0014-27
Figure 106122049-A0101-12-0014-27

Figure 106122049-A0101-12-0014-28
Figure 106122049-A0101-12-0014-28

Figure 106122049-A0101-12-0014-29
Figure 106122049-A0101-12-0014-29

前述之二胺化合物(b-1)可單獨一種使用或混合複數種使用。 The aforementioned diamine compound (b-1) may be used singly or in combination of plural kinds.

基於二胺化合物(b)之總使用量為100莫耳,二胺化合物(b-1)之使用量為3莫耳至45莫耳,較佳為6莫耳至40莫耳,且更佳為9莫耳至35莫耳。 Based on the total usage amount of the diamine compound (b) is 100 mol, the usage amount of the diamine compound (b-1) is 3 mol to 45 mol, preferably 6 mol to 40 mol, and more preferably It is 9 mol to 35 mol.

若液晶配向劑之二胺化合物(b)包含如式(II)所示之二胺化合物(b-1)時,所製得之液晶配向膜具有較高楊氏模量,而可進一步改善液晶顯示元件之碎亮點缺陷。 If the diamine compound (b) of the liquid crystal alignment agent contains the diamine compound (b-1) represented by formula (II), the resulting liquid crystal alignment film has a higher Young's modulus, which can further improve the liquid crystal Broken bright spots of display components.

二胺化合物(b-2)Diamine compound (b-2)

該二胺化合物(b-2)具有如下式(III)所示之結構:

Figure 106122049-A0101-12-0014-30
The diamine compound (b-2) has a structure represented by the following formula (III):
Figure 106122049-A0101-12-0014-30

於式(III)中,該y代表1至12之整數。 In formula (III), the y represents an integer of 1-12.

在一實施例中,具有如式(III)所示之結構的二胺化合物(b-2)可包含具有如下式(III-1)至式(III-3)所示之結構的二胺化合物:

Figure 106122049-A0101-12-0015-31
In one embodiment, the diamine compound (b-2) having the structure shown in formula (III) may include the diamine compound having the structure shown in the following formula (III-1) to formula (III-3) :
Figure 106122049-A0101-12-0015-31

Figure 106122049-A0101-12-0015-32
Figure 106122049-A0101-12-0015-32

Figure 106122049-A0101-12-0015-33
Figure 106122049-A0101-12-0015-33

於式(III-1)至式(III-3)中,y可代表1至12之整數。 In formula (III-1) to formula (III-3), y may represent an integer of 1-12.

前述具有如式(III-1)所示之結構的二胺化合物之具體例可為二(4-胺基苯氧基)甲烷、1,2-二(4-胺基苯氧基)乙烷、1,3-二(4-胺基苯氧基)丙烷、1,4-二(4-胺基苯氧基)丁烷、1,5-二(4-胺基苯氧基)戊烷、1,6-二(4-胺基苯氧基)己烷、1,7-二(4-胺基苯氧基)庚烷、1,8-二(4-胺基苯氧基)辛烷、1,9-二(4-胺基苯氧基)壬烷、1,10-二(4-胺基苯氧基)癸烷或上述化合物之任意混合。 Specific examples of the aforementioned diamine compound having the structure shown in formula (III-1) can be bis(4-aminophenoxy)methane, 1,2-bis(4-aminophenoxy)ethane , 1,3-bis(4-aminophenoxy)propane, 1,4-bis(4-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane , 1,6-bis(4-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane Alkane, 1,9-bis(4-aminophenoxy)nonane, 1,10-bis(4-aminophenoxy)decane, or any mixture of the above compounds.

前述具有如式(III-2)所示之結構的二胺化合物之具體例可為二(2-胺基苯氧基)甲烷、1,2-二(2-胺基苯氧基)乙烷、1,3-二(2-胺基苯氧基)丙烷、1,4-二(2-胺基苯氧基)丁烷、1,5-二(2-胺基苯氧基)戊烷、1,6-二(2-胺基苯氧基)己烷、1,7-二(2-胺基苯氧基)庚烷、1,8-二(2-胺基苯 氧基)辛烷、1,9-二(2-胺基苯氧基)壬烷、1,10-二(2-胺基苯氧基)癸烷或上述化合物之任意混合。 Specific examples of the aforementioned diamine compound having the structure shown in formula (III-2) can be bis(2-aminophenoxy)methane, 1,2-bis(2-aminophenoxy)ethane , 1,3-bis(2-aminophenoxy)propane, 1,4-bis(2-aminophenoxy)butane, 1,5-bis(2-aminophenoxy)pentane , 1,6-bis(2-aminophenoxy)hexane, 1,7-bis(2-aminophenoxy)heptane, 1,8-bis(2-aminophenoxy)octane Alkane, 1,9-bis(2-aminophenoxy)nonane, 1,10-bis(2-aminophenoxy)decane, or any mixture of the above compounds.

前述具有如式(III-3)所示之結構的二胺化合物之具體例可為二(3-胺基苯氧基)甲烷、1,2-二(3-胺基苯氧基)乙烷、1,3-二(3-胺基苯氧基)丙烷、1,4-二(3-胺基苯氧基)丁烷、1,5-二(3-胺基苯氧基)戊烷、1,6-二(3-胺基苯氧基)己烷、1,7-二(3-胺基苯氧基)庚烷、1,8-二(3-胺基苯氧基)辛烷、1,9-二(3-胺基苯氧基)壬烷、1,10-二(3-胺基苯氧基)癸烷或上述化合物之任意混合。 Specific examples of the aforementioned diamine compound having the structure shown in formula (III-3) can be bis(3-aminophenoxy)methane, 1,2-bis(3-aminophenoxy)ethane , 1,3-bis(3-aminophenoxy)propane, 1,4-bis(3-aminophenoxy)butane, 1,5-bis(3-aminophenoxy)pentane , 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(3-aminophenoxy)heptane, 1,8-bis(3-aminophenoxy)octane Alkane, 1,9-bis(3-aminophenoxy)nonane, 1,10-bis(3-aminophenoxy)decane, or any mixture of the above compounds.

較佳地,具有如式(III)所示之結構的二胺化合物(b-2)之具體例可為1,3-二(4-胺基苯氧基)丙烷、1,4-二(4-胺基苯氧基)丁烷、1,5-二(4-胺基苯氧基)戊烷、1,6-二(4-胺基苯氧基)己烷、1,7-二(4-胺基苯氧基)庚烷、1,8-二(4-胺基苯氧基)辛烷、1,3-二(2-胺基苯氧基)丙烷、1,4-二(2-胺基苯氧基)丁烷、1,5-二(2-胺基苯氧基)戊烷、1,6-二(2-胺基苯氧基)己烷、1,7-二(2-胺基苯氧基)庚烷、1,8-二(2-胺基苯氧基)辛烷、1,3-二(3-胺基苯氧基)丙烷、1,4-二(3-胺基苯氧基)丁烷、1,5-二(3-胺基苯氧基)戊烷、1,6-二(3-胺基苯氧基)己烷、1,7-二(3-胺基苯氧基)庚烷或1,8-二(3-胺基苯氧基)辛烷等。前述之二胺化合物(b-2)可單獨一種使用或混合複述種使用。 Preferably, specific examples of the diamine compound (b-2) having the structure shown in formula (III) may be 1,3-bis(4-aminophenoxy)propane, 1,4-bis( 4-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,7-bis (4-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,3-bis(2-aminophenoxy)propane, 1,4-bis (2-aminophenoxy)butane, 1,5-bis(2-aminophenoxy)pentane, 1,6-bis(2-aminophenoxy)hexane, 1,7- Bis(2-aminophenoxy)heptane, 1,8-bis(2-aminophenoxy)octane, 1,3-bis(3-aminophenoxy)propane, 1,4- Bis(3-aminophenoxy)butane, 1,5-bis(3-aminophenoxy)pentane, 1,6-bis(3-aminophenoxy)hexane, 1,7 -Di(3-aminophenoxy)heptane or 1,8-bis(3-aminophenoxy)octane, etc. The aforementioned diamine compound (b-2) can be used singly or as a mixture of multiple types.

基於二胺化合物(b)之總使用量為100莫耳,二胺化合物(b-2)之使用量為10莫耳至95莫耳,較佳為15莫耳至90莫耳,且更佳為20莫耳至85莫耳。 Based on the total usage amount of the diamine compound (b) being 100 mol, the usage amount of the diamine compound (b-2) is 10 mol to 95 mol, preferably 15 mol to 90 mol, and more preferably From 20 mol to 85 mol.

若液晶配向劑之二胺化合物(b)包含如式(III)所示之二胺化合物(b-2)時,所製得之液晶配向膜具有較高楊氏模量,而可進一步改善液晶顯示元件之碎亮點缺陷。 If the diamine compound (b) of the liquid crystal alignment agent contains the diamine compound (b-2) represented by the formula (III), the resulting liquid crystal alignment film has a higher Young's modulus, which can further improve the liquid crystal Broken bright spots of display components.

若液晶配向劑之二胺化合物(b)同時包含如式(II)所示之二胺化合物(b-1)及如式(III)所示之二胺化合物(b-2)時,所製得之液晶配向膜可具有更高楊氏模量,而可進一步改善液晶顯示元件之碎亮點缺陷。 If the diamine compound (b) of the liquid crystal alignment agent contains both the diamine compound (b-1) represented by formula (II) and the diamine compound (b-2) represented by formula (III), the prepared The obtained liquid crystal alignment film can have a higher Young's modulus, and can further improve the broken bright spot defects of the liquid crystal display element.

其他二胺化合物(b-3)Other diamine compounds (b-3)

除前述之二胺化合物(b-1)及/或二胺化合物(b-2)以外,在不影響功效的範圍內,本發明的二胺化合物(b)亦可選擇性地包含其他二胺化合物(b-3)。 In addition to the aforementioned diamine compound (b-1) and/or diamine compound (b-2), the diamine compound (b) of the present invention may optionally contain other diamines within the range that does not affect the efficacy Compound (b-3).

其他二胺化合物(b-3)可包含但不限於1,2-二胺基乙烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、4,4'-二胺基庚烷、1,3-二胺基-2,2-二甲基丙烷、1,6-二胺基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、1,9-二胺基-5-甲基壬烷、2,11-二胺基十二烷、1,12-二胺基十八烷、1,2-雙(3-胺基丙氧基)乙烷、4,4'-二胺基二環己基甲烷、4,4'-二胺基-3,3'-二甲基二環己基胺、1,3-二胺基環己烷、1,4-二胺基環己烷、異佛爾酮二胺、四氫二環戊二烯二胺、三環(6.2.1.02,7)-十一碳烯二甲基二胺、4,4'-亞甲基雙(環己基胺)、4,4'-二胺基二苯基甲烷、4,4'-二胺基二苯基乙烷、4,4'-二 胺基二苯基碸、4,4'-二胺基苯甲醯苯胺、4,4'-二胺基二苯基醚、3,4'-二胺基二苯基醚、1,5-二胺基萘、5-胺基-1-(4'-胺基苯基)-1,3,3-三甲基氫茚、6-胺基-1-(4'-胺基苯基)-1,3,3-三甲基氫茚、六氫-4,7-甲橋伸氫茚基二亞甲基二胺、3,3'-二胺基二苯甲酮、3,4'-二胺基二苯甲酮、4,4'-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4-胺基苯基)-10-氫蒽、9,10-雙(4-胺基苯基)蒽[9,10-bis(4-aminophenyl)anthracene]、2,7-二胺基茀、9,9-雙(4-胺基苯基)茀、4,4'-亞甲基-雙(2-氯苯胺)、4,4'-(對-伸苯基異亞丙基)雙苯胺、4,4'-(間-伸苯基異亞丙基)雙苯胺、2,2'-雙[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4'-雙[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯{5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene}、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷{1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethyl phenyl)cyclohexane}或如下式(V-1)至式(V-29)所示之其他二胺化合物。 Other diamine compounds (b-3) may include, but are not limited to, 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminobutane Pentane, 1,6-Diaminohexane, 1,7-Diaminoheptane, 1,8-Diaminooctane, 1,9-Diaminononane, 1,10-Diamino Decane, 4,4'-diaminoheptane, 1,3-diamino-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1 ,7-diamino-2,5-dimethylheptane, 1,7-diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1,9-diamino-5-methylnonane, 2,11-diaminododecane, 1,12-diaminooctadecane, 1,2-bis(3-aminopropoxy ) Ethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diamino-3,3'-dimethyldicyclohexylamine, 1,3-diaminocyclohexane, 1,4-Diaminocyclohexane, isophorone diamine, tetrahydrodicyclopentadiene diamine, tricyclic (6.2.1.0 2,7 )-undecene dimethyl Diamine, 4,4'-methylenebis(cyclohexylamine), 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4,4'- Diaminodiphenyl sulfide, 4,4'-diaminobenzaniline, 4,4'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 1,5 -Diaminonaphthalene, 5-amino-1-(4'-aminophenyl)-1,3,3-trimethylhydroindene, 6-amino-1-(4'-aminophenyl) )-1,3,3-trimethylindenyl, hexahydro-4,7-methane-bridged indenyldimethylene diamine, 3,3'-diaminobenzophenone, 3,4 '-Diaminobenzophenone, 4,4'-Diaminobenzophenone, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis [4-(4-Aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminobenzene) (Oxy) phenyl) chrysene, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-amino) Phenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroanthracene, 9,10-bis(4-aminophenyl)anthracene [9,10-bis(4-aminophenyl) anthracene], 2,7-diaminopyridine, 9,9-bis(4-aminophenyl)pyridine, 4,4'-methylene-bis(2-chloroaniline), 4,4'-( P-phenylene isopropylidene) bisaniline, 4,4'-(m-phenylene isopropylidene) bisaniline, 2,2'-bis[4-(4-amino-2-tri Fluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, 5-[4-( 4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene {5-[4-(4-n-pentylcycloh exyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene}, 1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane{1, 1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethyl phenyl)cyclohexane} or other diamine compounds represented by the following formulas (V-1) to (V-29).

Figure 106122049-A0101-12-0019-98
Figure 106122049-A0101-12-0019-98

於式(V-1)中,Y1代表-o-、

Figure 106122049-A0101-12-0019-36
Figure 106122049-A0101-12-0019-37
Figure 106122049-A0101-12-0019-38
Figure 106122049-A0101-12-0019-39
Figure 106122049-A0101-12-0019-40
,且Y2代表含甾基團、三氟甲基、氟基、碳數為2至30之烷基或衍生自吡啶、嘧啶、三嗪、哌啶及哌嗪等含氮原子環狀結構的一價基團。 In formula (V-1), Y 1 represents -o-,
Figure 106122049-A0101-12-0019-36
,
Figure 106122049-A0101-12-0019-37
,
Figure 106122049-A0101-12-0019-38
,
Figure 106122049-A0101-12-0019-39
or
Figure 106122049-A0101-12-0019-40
, And Y 2 represents a steroid-containing group, a trifluoromethyl group, a fluoro group, an alkyl group with a carbon number of 2 to 30 or those derived from pyridine, pyrimidine, triazine, piperidine and piperazine and other nitrogen-containing ring structures Monovalent group.

上式(V-1)所示之其他二胺化合物較佳可為2,4-二胺基苯基甲酸乙酯(2,4-diaminophenyl ethyl formate)、3,5-二胺基苯基甲酸乙酯(3,5-diaminophenyl ethyl formate)、2,4-二胺基苯基甲酸丙酯(2,4-diaminophenyl propyl formate)、3,5-二胺基苯基甲酸丙酯(3,5-diaminophenyl propyl formate)、1-十二烷氧基-2,4-二胺基苯(1-dodecoxy-2,4-diamino-benzene)、1-十六烷氧基-2,4-二胺基苯(1-hexadecoxy-2,4-diaminobenzene)、1-十八烷氧基-2,4-二胺基苯(1-octadecoxy-2,4-diaminobenzene)或下式(V-1-1)至式(V-1-6)所示之其他二胺化合物。 The other diamine compound represented by the above formula (V-1) may preferably be 2,4-diaminophenyl ethyl formate (2,4-diaminophenyl ethyl formate), 3,5-diaminophenyl ethyl formate Ethyl (3,5-diaminophenyl ethyl formate), 2,4-diaminophenyl propyl formate (2,4-diaminophenyl propyl formate), 3,5-diaminophenyl propyl formate (3,5 -diaminophenyl propyl formate), 1-dodecoxy-2,4-diamino-benzene (1-dodecoxy-2,4-diamino-benzene), 1-hexadecoxy-2,4-diamine Benzene (1-hexadecoxy-2,4-diaminobenzene), 1-octadecoxy-2,4-diaminobenzene (1-octadecoxy-2,4-diaminobenzene) or the following formula (V-1-1 ) To other diamine compounds represented by formula (V-1-6).

Figure 106122049-A0101-12-0019-35
Figure 106122049-A0101-12-0019-35

Figure 106122049-A0101-12-0020-41
Figure 106122049-A0101-12-0020-41

Figure 106122049-A0101-12-0020-43
Figure 106122049-A0101-12-0020-43

Figure 106122049-A0101-12-0020-44
Figure 106122049-A0101-12-0020-44

Figure 106122049-A0101-12-0020-45
Figure 106122049-A0101-12-0020-45

Figure 106122049-A0101-12-0021-46
Figure 106122049-A0101-12-0021-46

Figure 106122049-A0101-12-0021-47
Figure 106122049-A0101-12-0021-47

於式(V-2)中,Y3代表-o-、

Figure 106122049-A0101-12-0021-50
Figure 106122049-A0101-12-0021-51
Figure 106122049-A0101-12-0021-52
Figure 106122049-A0101-12-0021-53
Figure 106122049-A0101-12-0021-55
,Y4及Y5表示伸脂肪族環、伸芳香族環或伸雜環基團,且Y6代表碳數為3至18之烷基、碳數為3至18之烷氧基、碳數為1至5之氟烷基、碳數為1至5之氟烷氧基、氰基或鹵素原子。 In formula (V-2), Y 3 represents -o-,
Figure 106122049-A0101-12-0021-50
,
Figure 106122049-A0101-12-0021-51
,
Figure 106122049-A0101-12-0021-52
,
Figure 106122049-A0101-12-0021-53
or
Figure 106122049-A0101-12-0021-55
, Y 4 and Y 5 represent an aliphatic ring, an aromatic ring or a heterocyclic ring group, and Y 6 represents an alkyl group with a carbon number of 3 to 18, an alkoxy group with a carbon number of 3 to 18, and a carbon number It is a fluoroalkyl group of 1 to 5, a fluoroalkoxy group of 1 to 5 carbon atoms, a cyano group or a halogen atom.

上式(V-2)所示之其他二胺化合物較佳可為如下式(V-2-1)至式(V-2-13)所示之二胺化合物:

Figure 106122049-A0101-12-0021-97
The other diamine compound represented by the above formula (V-2) may preferably be the diamine compound represented by the following formula (V-2-1) to formula (V-2-13):
Figure 106122049-A0101-12-0021-97

Figure 106122049-A0101-12-0021-49
Figure 106122049-A0101-12-0021-49

Figure 106122049-A0101-12-0022-56
Figure 106122049-A0101-12-0022-56

Figure 106122049-A0101-12-0022-57
Figure 106122049-A0101-12-0022-57

Figure 106122049-A0101-12-0022-58
Figure 106122049-A0101-12-0022-58

Figure 106122049-A0101-12-0022-59
Figure 106122049-A0101-12-0022-59

Figure 106122049-A0101-12-0022-60
Figure 106122049-A0101-12-0022-60

Figure 106122049-A0101-12-0022-61
Figure 106122049-A0101-12-0022-61

Figure 106122049-A0101-12-0023-62
Figure 106122049-A0101-12-0023-62

Figure 106122049-A0101-12-0023-63
Figure 106122049-A0101-12-0023-63

Figure 106122049-A0101-12-0023-64
Figure 106122049-A0101-12-0023-64

Figure 106122049-A0101-12-0023-65
Figure 106122049-A0101-12-0023-65

Figure 106122049-A0101-12-0023-66
Figure 106122049-A0101-12-0023-66

於式(V-2-10)至式(V-2-13)中,s可代表3至12之整數。 In formulas (V-2-10) to (V-2-13), s may represent an integer from 3 to 12.

Figure 106122049-A0101-12-0023-68
Figure 106122049-A0101-12-0023-68

於式(V-3)中,Y7代表氫原子、碳數為1至5的醯基、碳數為1至5的烷基、碳數為1至5的烷氧基或鹵素。Y8 為1至3的整數。當Y8大於1時,複數個Y7可為相同或不同。 In formula (V-3), Y 7 represents a hydrogen atom, an acyl group having 1 to 5 carbons, an alkyl group having 1 to 5 carbons, an alkoxy group having 1 to 5 carbons, or halogen. Y 8 is an integer from 1 to 3. When Y 8 is greater than 1, a plurality of Y 7 may be the same or different.

上述式(V-3)所示之二胺化合物較佳是選自於(1)Y8為1:對-二胺苯、間-二胺苯、鄰-二胺苯或2,5-二胺甲苯等;(2)Y8為2:4,4'-二胺基聯苯、2,2'-二甲基-4,4'-二胺基聯苯、3,3'-二甲基-4,4'-二胺基聯苯、3,3'-二甲氧基-4,4'-二胺基聯苯、2,2'-二氯-4,4'-二胺基聯苯、3,3'-二氯-4,4'-二胺基聯苯、2,2',5,5'-四氯-4,4'-二胺基聯苯、2,2'-二氯-4,4'-二胺基-5,5'-二甲氧基聯苯或4,4'-二胺基-2,2'-雙(三氟甲基)聯苯等;(3)Y8為3:1,4-雙(4'-胺基苯基)苯等,更佳是選自於對-二胺苯、2,5-二胺甲苯、4,4'-二胺基聯苯、3,3'-二甲氧基-4,4'-二胺基聯苯或1,4-雙(4'-胺基苯基)苯。 The diamine compound represented by the above formula (V-3) is preferably selected from (1) Y 8 is 1: p-diaminobenzene, m-diaminobenzene, o-diaminobenzene or 2,5-diaminobenzene Aminotoluene, etc.; (2) Y 8 is 2:4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethyl -4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diamino Biphenyl, 3,3'-dichloro-4,4'-diaminobiphenyl, 2,2',5,5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-Dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl or 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, etc.; (3) Y 8 is 3: 1,4-bis(4'-aminophenyl)benzene, etc., more preferably selected from p-diaminobenzene, 2,5-diaminotoluene, 4,4'- Diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl or 1,4-bis(4'-aminophenyl)benzene.

Figure 106122049-A0101-12-0024-69
Figure 106122049-A0101-12-0024-69

於式(V-4)中,Y9代表1至5之整數。該式(V-4)較佳選自於4,4'-二胺基二苯基硫醚。 In the formula (V-4), Y 9 represents an integer of 1 to 5. The formula (V-4) is preferably selected from 4,4'-diaminodiphenyl sulfide.

Figure 106122049-A0101-12-0024-70
Figure 106122049-A0101-12-0024-70

於式(V-5)中,Y10及Y12可為相同或不同,且分別代表二價有機基團,Y11代表衍生自吡啶、嘧啶、三嗪、哌啶及哌嗪等含氮原子環狀結構的二價基團。 In formula (V-5), Y 10 and Y 12 can be the same or different, and represent a divalent organic group, respectively, and Y 11 represents a nitrogen-containing atom derived from pyridine, pyrimidine, triazine, piperidine, and piperazine A divalent group in a cyclic structure.

式(V-5)所示之二胺化合物較佳可為如下式(V-5-1)所示之二胺化合物:

Figure 106122049-A0101-12-0025-71
The diamine compound represented by the formula (V-5) may preferably be a diamine compound represented by the following formula (V-5-1):
Figure 106122049-A0101-12-0025-71

Figure 106122049-A0101-12-0025-72
Figure 106122049-A0101-12-0025-72

於式(V-6)中,Y13、Y14、Y15及Y16分別可為相同或不同,且可代表碳數為1至12的烴基。Y17代表1至3之整數,且Y18代表1至20之整數。 In formula (V-6), Y 13 , Y 14 , Y 15 and Y 16 may be the same or different, respectively, and may represent a hydrocarbon group having 1 to 12 carbon atoms. Y 17 represents an integer from 1 to 3, and Y 18 represents an integer from 1 to 20.

Figure 106122049-A0101-12-0025-73
Figure 106122049-A0101-12-0025-73

於式(V-7)中,Y19代表-o-或伸環己烷基,Y20代表-CH2-,Y21代表伸苯基或伸環己烷基,且Y22代表氫原子或庚基。 In the formula (V-7), Y 19 represents -o- or cyclohexylene, Y 20 represents -CH 2 -, Y 21 represents phenylene or cyclohexylene, and Y 22 represents a hydrogen atom or Heptyl.

上述式(V-7)所示之二胺化合物較佳選自於如下式(V-7-1)及式(V-7-2)所示之二胺化合物。 The diamine compound represented by the above formula (V-7) is preferably selected from the diamine compounds represented by the following formula (V-7-1) and formula (V-7-2).

Figure 106122049-A0101-12-0025-74
Figure 106122049-A0101-12-0025-74

Figure 106122049-A0101-12-0025-75
Figure 106122049-A0101-12-0025-75

式(V-8)至式(V-29)所示之其他二胺化合物(b-3)如下所示:

Figure 106122049-A0101-12-0026-78
Other diamine compounds (b-3) represented by formula (V-8) to formula (V-29) are as follows:
Figure 106122049-A0101-12-0026-78

Figure 106122049-A0101-12-0027-79
Figure 106122049-A0101-12-0027-79

Figure 106122049-A0101-12-0028-80
Figure 106122049-A0101-12-0028-80

Figure 106122049-A0101-12-0028-81
Figure 106122049-A0101-12-0028-81

Figure 106122049-A0101-12-0028-82
Figure 106122049-A0101-12-0028-82

Figure 106122049-A0101-12-0028-83
Figure 106122049-A0101-12-0028-83

Figure 106122049-A0101-12-0028-84
Figure 106122049-A0101-12-0028-84

Figure 106122049-A0101-12-0028-85
Figure 106122049-A0101-12-0028-85

Figure 106122049-A0101-12-0028-86
Figure 106122049-A0101-12-0028-86

Figure 106122049-A0101-12-0028-88
Figure 106122049-A0101-12-0028-88

於式(V-16)至式(V-19)中,Y23以碳數為1至10之烷基或碳數為1至10之烷氧基為較佳。於式(V-20)至式(V-24)中,Y24以氫原子、碳數為1至10之烷基或碳數為1至10之烷氧基為較佳。 In formulas (V-16) to (V-19), Y 23 is preferably an alkyl group having 1 to 10 carbons or an alkoxy group having 1 to 10 carbons. In formulas (V-20) to (V-24), Y 24 is preferably a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or an alkoxy group having 1 to 10 carbon atoms.

其他二胺化合物(b-3)較佳可包含但不限於1,2-二胺基乙烷、4,4'-二胺基二環己基甲烷、4,4'-二胺基二苯基甲烷、4,4'-二胺基二苯基醚、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷、2,4-二胺基苯基甲酸乙酯、對-二胺苯、間-二胺苯、鄰-二胺苯、式(V-1-1)、式(V-1-2)、式(V-1-5)、式(V-2-1)、式(V-2-11)、式(V-7-1)、式(V-25)或式(V-28)所表示的化合物。 Other diamine compounds (b-3) may preferably include but are not limited to 1,2-diaminoethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diaminodiphenyl Methane, 4,4'-diaminodiphenyl ether, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene, 1, 1-Bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane, ethyl 2,4-diaminophenylcarboxylate, p-diamine Benzene, m-diaminobenzene, o-diaminobenzene, formula (V-1-1), formula (V-1-2), formula (V-1-5), formula (V-2-1), A compound represented by formula (V-2-11), formula (V-7-1), formula (V-25), or formula (V-28).

前述之其他二胺化合物(b-3)可單獨一種或混合複數種使用。 The aforementioned other diamine compound (b-3) may be used alone or in combination of plural kinds.

基於二胺化合物(b)之總使用量為100莫耳,其他二胺化合物(b-3)之使用量為0莫耳至97莫耳,較佳為0莫耳至94莫耳,且更佳為0莫耳至91莫耳。 Based on the total usage amount of the diamine compound (b) being 100 mol, the usage amount of other diamine compounds (b-3) is 0 mol to 97 mol, preferably 0 mol to 94 mol, and more Preferably, it is 0 mol to 91 mol.

聚合物(A)的製造方法Manufacturing method of polymer (A)

根據本發明之聚醯胺酸聚合物之製備可為一般之方法,較佳地,該聚醯胺酸聚合物之製備方法包含以下步驟:將包括四羧酸二酐化合物(a)與二胺化合物(b)之混合物溶於溶劑中,在0℃至100℃之溫度條件下進行聚縮合反應並反應1小時至24小時,接著再將上述之反應溶液以蒸發器 進行減壓蒸餾方式,即可得到聚醯胺酸聚合物,或者將上述之反應溶液倒入大量之貧溶劑中,得到一析出物,接著經由減壓乾燥方式將該析出物進行乾燥處理,即可得到聚醯胺酸聚合物。 The preparation of the polyamide acid polymer according to the present invention can be a general method. Preferably, the preparation method of the polyamide acid polymer comprises the following steps: a tetracarboxylic dianhydride compound (a) and a diamine The mixture of compound (b) is dissolved in a solvent, and the polycondensation reaction is carried out at a temperature of 0°C to 100°C and reacted for 1 hour to 24 hours, and then the above reaction solution is subjected to reduced pressure distillation with an evaporator, namely Polyamide acid polymer can be obtained, or the above reaction solution is poured into a large amount of poor solvent to obtain a precipitate, and then the precipitate is dried by a vacuum drying method to obtain polyamide acid polymerization Things.

用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑相同或不同,且用於聚縮合反應中的溶劑並無特別的限制,只要是可溶解反應物與生成物即可。較佳地,溶劑包含但不限於(1)非質子系極性溶劑,例如:N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidinone;NMP)、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、二甲基亞碸、γ-丁內酯、四甲基尿素或六甲基磷酸三胺等之非質子系極性溶劑;(2)酚系溶劑,例如:間-甲酚、二甲苯酚、酚或鹵化酚類等之酚系溶劑。基於混合物之使用量為100重量份,用於聚縮合反應中之溶劑的使用量較佳為200重量份至2000重量份,且更佳為300重量份至1800重量份。 The solvent used in the polycondensation reaction may be the same as or different from the solvent in the following liquid crystal alignment agent, and the solvent used in the polycondensation reaction is not particularly limited, as long as it can dissolve the reactants and products. Preferably, the solvent includes but is not limited to (1) aprotic polar solvent, for example: N-methyl-2-pyrrolidinone (NMP), N,N-dimethylacetamide , N,N-dimethylformamide, dimethyl sulfide, γ-butyrolactone, tetramethylurea or hexamethyltriamine phosphate and other aprotic polar solvents; (2) Phenolic solvents, For example: phenolic solvents such as m-cresol, xylenol, phenol or halogenated phenols. Based on 100 parts by weight of the mixture, the solvent used in the polycondensation reaction is preferably 200 parts by weight to 2000 parts by weight, and more preferably 300 parts by weight to 1800 parts by weight.

特別地,於聚縮合反應中,溶劑可併用適量的貧溶劑,其中貧溶劑不會造成聚醯胺酸聚合物析出。貧溶劑可以單獨一種使用或者混合複數種使用,且其包含但不限於(1)醇類,例如:甲醇、乙醇、異丙醇、環己醇、乙二醇、丙二醇、1,4-丁二醇或三乙二醇等之醇類;(2)酮類,例如:丙酮、甲基乙基酮、甲基異丁基酮或環己酮等之酮類;(3)酯類,例如:醋酸甲酯、醋酸乙酯、醋酸丁酯、草酸二乙酯、丙二酸二乙酯或乙二醇乙基醚醋酸酯等之酯類;(4)醚類,例如:二乙基醚、乙二醇甲基醚、乙二醇乙基醚、乙二醇正 丙基醚、乙二醇異丙基醚、乙二醇正丁基醚、乙二醇二甲基醚或二乙二醇二甲基醚等之醚類;(5)鹵化烴類,例如:二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯或鄰-二氯苯等之鹵化烴類;(6)烴類,例如:四氫呋喃、己烷、庚烷、辛烷、苯、甲苯或二甲苯等之烴類或上述溶劑之任意組合。基於二胺化合物(b)的使用量為100重量份,貧溶劑的使用量較佳為0重量份至60重量份,且更佳為0重量份至50重量份。 In particular, in the polycondensation reaction, the solvent can be used in combination with an appropriate amount of poor solvent, where the poor solvent will not cause the precipitation of the polyamide acid polymer. The poor solvent can be used alone or in a mixture of multiple, and it includes but is not limited to (1) alcohols, for example: methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanedi Alcohols such as alcohols or triethylene glycol; (2) Ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone, or cyclohexanone; (3) Esters, such as: Esters such as methyl acetate, ethyl acetate, butyl acetate, diethyl oxalate, diethyl malonate or ethylene glycol ethyl ether acetate; (4) ethers, such as diethyl ether, Ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether (5) Halogenated hydrocarbons, such as dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene or o-dichloro Halogenated hydrocarbons such as benzene; (6) Hydrocarbons, such as hydrocarbons such as tetrahydrofuran, hexane, heptane, octane, benzene, toluene or xylene, or any combination of the above solvents. Based on the usage amount of the diamine compound (b) being 100 parts by weight, the usage amount of the poor solvent is preferably 0 parts by weight to 60 parts by weight, and more preferably 0 parts by weight to 50 parts by weight.

本發明之聚醯亞胺聚合物之製備可為一般之方法,較佳地,聚醯亞胺聚合物之製備方法先將一混合物溶解於溶液中,其中混合物包含四羧酸二酐化合物(a)與二胺化合物(b),並進行聚合反應,以形成聚醯胺酸聚合物。接著,在脫水劑及觸媒的存在下,進一步加熱,並進行脫水閉環反應,使得聚醯胺酸聚合物中的醯胺酸官能基經由脫水閉環反應轉變成醯亞胺官能基(即醯亞胺化),而得到聚醯亞胺聚合物。 The preparation of the polyimide polymer of the present invention can be a general method. Preferably, the preparation method of the polyimide polymer first dissolves a mixture in a solution, wherein the mixture contains a tetracarboxylic dianhydride compound (a ) And the diamine compound (b), and carry out a polymerization reaction to form a polyamide acid polymer. Then, in the presence of a dehydrating agent and a catalyst, further heating and dehydration and ring-closing reaction are carried out, so that the amide functional group in the polyamide acid polymer is converted into an amide functional group (ie, amide Amination) to obtain polyimide polymer.

用於脫水閉環反應中之溶劑可與下述液晶配向劑中的溶劑相同,故不另贅述。基於聚醯胺酸聚合物的使用量為100重量份,用於脫水閉環反應中的溶劑的使用量較佳為200重量份至2000重量份,且更佳為300重量份至1800重量份。 The solvent used in the dehydration ring-closing reaction can be the same as the solvent in the following liquid crystal alignment agent, so it will not be repeated. Based on the usage amount of the polyamide acid polymer being 100 parts by weight, the usage amount of the solvent used in the dehydration ring-closure reaction is preferably 200 parts by weight to 2000 parts by weight, and more preferably 300 parts by weight to 1800 parts by weight.

為獲得較佳之聚醯胺酸聚合物的醯亞胺化程度,脫水閉環反應的操作溫度較佳為40℃至200℃,且更佳為40℃至150℃。若脫水閉環反應的操作溫度低於40℃時, 醯亞胺化之反應不完全,而降低聚醯胺酸聚合物的醯亞胺化程度。然而,若脫水閉環反應的操作溫度高於200℃時,所得的聚醯亞胺聚合物的重量平均分子量偏低。 In order to obtain a better degree of imidization of the polyamide acid polymer, the operating temperature of the dehydration and ring-closure reaction is preferably 40°C to 200°C, and more preferably 40°C to 150°C. If the operating temperature of the dehydration ring-closing reaction is lower than 40°C, the imidization reaction is incomplete, and the degree of imidization of the polyamide acid polymer is reduced. However, if the operating temperature of the dehydration and ring-closure reaction is higher than 200°C, the weight average molecular weight of the obtained polyimide polymer is low.

用於脫水閉環反應中的脫水劑可選自於酸酐類化合物,其具體例如:醋酸酐、丙酸酐或三氟醋酸酐等之酸酐類化合物。基於聚醯胺酸聚合物為1莫耳,脫水劑的使用量為0.01莫耳至20莫耳。用於脫水閉環反應中的觸媒可選自於(1)吡啶類化合物,例如:吡啶、三甲基吡啶或二甲基吡啶等之吡啶類化合物;(2)三級胺類化合物,例如:三乙基胺等之三級胺類化合物。基於脫水劑的使用量為1莫耳,觸媒的使用量為0.5莫耳至10莫耳。 The dehydrating agent used in the dehydration ring-closing reaction may be selected from acid anhydride compounds, specifically such as acetic anhydride, propionic anhydride, or trifluoroacetic anhydride. Based on 1 mol of the polyamide acid polymer, the amount of the dehydrating agent used is 0.01 mol to 20 mol. The catalyst used in the dehydration ring-closure reaction can be selected from (1) pyridine compounds, such as pyridine, collidine or lutidine; (2) tertiary amine compounds, such as: Tertiary amine compounds such as triethylamine. Based on the usage amount of the dehydrating agent is 1 mol, the usage amount of the catalyst is 0.5 mol to 10 mol.

本發明之聚醯亞胺系嵌段共聚合物之較佳具體例為聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物,或此等之任意組合。 Preferred specific examples of the polyimide block copolymer of the present invention are polyimide block copolymer, polyimide block copolymer, polyimide-polyimide block Copolymer, or any combination of these.

本發明之聚醯亞胺系嵌段共聚合物之製備可為一般之方法,較佳地,聚醯亞胺系嵌段共聚合物之製備方法先將一起始物溶解於溶劑中,並進行聚縮合反應,其中所述起始物包括上述之至少一種聚醯胺酸聚合物及/或上述之至少一種聚醯亞胺聚合物,且可進一步地包括四羧酸二酐化合物(a)及二胺化合物(b)。 The preparation of the polyimine-based block copolymer of the present invention can be a general method. Preferably, the preparation method of the polyimine-based block copolymer is first to dissolve a starting material in a solvent and proceed A polycondensation reaction, wherein the starting material includes the above-mentioned at least one polyamide acid polymer and/or the above-mentioned at least one polyimide polymer, and may further include a tetracarboxylic dianhydride compound (a) and Diamine compound (b).

所述起始物中之四羧酸二酐化合物(a)與二胺化合物(b)是與上述製備聚醯胺酸聚合物中所使用的四羧酸二酐化合物(a)與二胺化合物(b)相同,且用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑相同,在此不另贅述。 The tetracarboxylic dianhydride compound (a) and diamine compound (b) in the starting material are the same as the tetracarboxylic dianhydride compound (a) and diamine compound used in the preparation of polyamide acid polymers. (b) It is the same, and the solvent used in the polycondensation reaction can be the same as the solvent in the following liquid crystal alignment agent, which will not be repeated here.

基於起始物的使用量為100重量份,用於聚縮合反應中之溶劑的使用量較佳為200重量份至2000重量份,且更佳為300重量份至1800重量份。聚縮合反應的操作溫度較佳為0℃至200℃,且更佳為0℃至100℃。 Based on 100 parts by weight of the starting material, the solvent used in the polycondensation reaction is preferably 200 parts by weight to 2000 parts by weight, and more preferably 300 parts by weight to 1800 parts by weight. The operating temperature of the polycondensation reaction is preferably 0°C to 200°C, and more preferably 0°C to 100°C.

較佳地,起始物包含但不限於(1)二種末端基相異且結構相異之聚醯胺酸聚合物;(2)二種末端基相異且結構相異之聚醯亞胺聚合物;(3)末端基相異且結構相異之聚醯胺酸聚合物及聚醯亞胺聚合物;(4)聚醯胺酸聚合物、四羧酸二酐化合物及二胺化合物,其中,四羧酸二酐化合物及二胺化合物之中的至少一種與形成聚醯胺酸聚合物所使用的四羧酸二酐化合物(a)及二胺化合物(b)的結構相異;(5)聚醯亞胺聚合物、四羧酸二酐化合物及二胺化合物,其中,所述四羧酸二酐化合物及二胺化合物中的至少一種與形成聚醯亞胺聚合物所使用的四羧酸二酐化合物(a)及二胺化合物(b)的結構相異;(6)聚醯胺酸聚合物、聚醯亞胺聚合物、四羧酸二酐化合物及二胺化合物,其中,四羧酸二酐化合物及二胺中的至少一種與形成聚醯胺酸聚合物或聚醯亞胺聚合物所使用的四羧酸二酐化合物(a)及二胺化合物(b)的結構相異;(7)二種結構相異之聚醯胺酸聚合物、四羧酸二酐化合物及二胺化合物;(8)二種結構相異之聚醯亞胺聚合物、四羧酸二酐化合物及二胺化合物;(9)二種末端基為酸酐基且結構相異的聚醯胺酸聚合物以及二胺化合物;(10)二種末端基為胺基且結構相異的聚醯胺酸聚合物以及四羧酸二酐化合物;(11)二種末端基為酸酐基且結構相異的聚醯 亞胺聚合物以及二胺化合物;(12)二種末端基為胺基且結構相異的聚醯亞胺聚合物以及四羧酸二酐化合物。 Preferably, the starting material includes but not limited to (1) two kinds of polyimide polymers with different end groups and different structures; (2) two kinds of polyimide polymers with different end groups and different structures Polymers; (3) Polyamide polymers and polyimide polymers with different end groups and different structures; (4) Polyamide polymers, tetracarboxylic dianhydride compounds and diamine compounds, Wherein, at least one of the tetracarboxylic dianhydride compound and the diamine compound has a different structure from the tetracarboxylic dianhydride compound (a) and the diamine compound (b) used to form the polyamide acid polymer; 5) Polyimide polymer, tetracarboxylic dianhydride compound and diamine compound, wherein at least one of the tetracarboxylic dianhydride compound and diamine compound is combined with the tetracarboxylic acid dianhydride compound used to form the polyimide polymer The structure of the carboxylic dianhydride compound (a) and the diamine compound (b) is different; (6) polyamide acid polymer, polyimide polymer, tetracarboxylic dianhydride compound and diamine compound, of which, At least one of the tetracarboxylic dianhydride compound and the diamine is in phase with the tetracarboxylic dianhydride compound (a) and the diamine compound (b) used to form the polyamide acid polymer or the polyimide polymer Different; (7) Two kinds of structurally different polyamide acid polymers, tetracarboxylic dianhydride compounds and diamine compounds; (8) Two kinds of structurally different polyimide polymers, tetracarboxylic dianhydride Compounds and diamine compounds; (9) Two kinds of polyamide acid polymers and diamine compounds whose end groups are acid anhydride groups and have different structures; (10) Two kinds of polyamides whose end groups are amine groups and have different structures Acid polymers and tetracarboxylic dianhydride compounds; (11) Two kinds of polyimide polymers and diamine compounds with acid anhydride groups and different structures; (12) Two kinds of end groups are amine groups and have the same structure Heteropolyimide polymers and tetracarboxylic dianhydride compounds.

在不影響本發明之功效範圍內,較佳地,該聚醯胺酸聚合物、該聚醯亞胺聚合物以及該聚醯亞胺系嵌段共聚合物可以是先進行分子量調節後的末端修飾型聚合物。藉由使用末端修飾型的聚合物,可改善液晶配向劑的塗佈性能。製備該末端修飾型聚合物的方式可藉由在聚醯胺酸聚合物進行聚縮合反應的同時,加入一單官能性化合物來製得,單官能性化合物可包含但不限於(1)一元酸酐,例如:馬來酸酐、鄰苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、正十四烷基琥珀酸酐或正十六烷基琥珀酸酐等之一元酸酐;(2)單胺化合物,例如:苯胺、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正十七烷胺、正十八烷胺或正二十烷胺等之單胺化合物;(3)單異氰酸酯化合物,例如:異氰酸苯酯或異氰酸萘基酯等之單異氰酸酯化合物。 In the range that does not affect the efficacy of the present invention, preferably, the polyimide polymer, the polyimide polymer and the polyimine-based block copolymer may be the terminal after the molecular weight is adjusted first. Modified polymer. By using end-modified polymers, the coating performance of the liquid crystal alignment agent can be improved. The method of preparing the terminal modified polymer can be prepared by adding a monofunctional compound while the polycondensation reaction of the polyamide acid polymer is carried out. The monofunctional compound may include but is not limited to (1) monobasic anhydride , Such as: maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl succinic anhydride or n-hexadecyl succinic anhydride, etc. (2) Monoamine compounds, such as: aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-nonylamine, n-decylamine, n-undecylamine, n- Monoamines such as dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecylamine, n-octadecylamine or n-eicosylamine Compound; (3) Monoisocyanate compounds, such as monoisocyanate compounds such as phenyl isocyanate or naphthyl isocyanate.

本發明的聚合物(A)根據凝膠滲透色層分析法所測得經聚苯乙烯換算的重量平均分子量為10,000至90,000,較佳為12,000至75,000,且更佳為15,000至60,000。 The polymer (A) of the present invention has a weight average molecular weight of 10,000 to 90,000, preferably 12,000 to 75,000, and more preferably 15,000 to 60,000 in terms of polystyrene as measured by gel permeation chromatography.

溶劑(B)Solvent (B)

根據本發明之溶劑(B)之較佳具體例為氮-甲基-2-吡咯烷酮、γ-丁內酯、γ-丁內醯胺、4-羥基-4-甲基-2-戊酮、乙二醇單甲基醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二甘醇二甲基醚、二甘醇二乙基醚、二甘醇單甲基醚、二甘醇單乙基醚、二甘醇單甲基醚乙酸酯、二甘醇單乙基醚乙酸酯、氮,氮-二甲基甲醯胺、氮,氮-二甲基乙醯胺。該溶劑可以單獨一種使用或者混合複數種使用。 The preferred specific examples of the solvent (B) according to the present invention are nitrogen-methyl-2-pyrrolidone, γ-butyrolactone, γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone, Ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl Base ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl Ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, nitrogen, nitrogen-dimethylformamide , Nitrogen, Nitrogen-Dimethylacetamide. The solvent can be used singly or in a mixture of plural kinds.

基於該聚合物(A)之使用量為100重量份,溶劑(B)的使用量可為500至3,000重量份,較佳為800至2,500重量份,且更佳1,000至2,000重量份。 Based on 100 parts by weight of the polymer (A), the solvent (B) may be used in an amount of 500 to 3,000 parts by weight, preferably 800 to 2,500 parts by weight, and more preferably 1,000 to 2,000 parts by weight.

添加劑(C)Additive (C)

在不影響本發明之功效範圍內,液晶配向劑可選擇性地添加添加劑(C),且添加劑(C)為環氧化合物或具有官能性基團之矽烷化合物等。添加劑(C)的作用是用來提高該液晶配向膜與基板表面的附著性。添加劑(C)可以單獨一種使用或者混合複數種使用。 In the range that does not affect the efficacy of the present invention, the liquid crystal alignment agent can be optionally added with the additive (C), and the additive (C) is an epoxy compound or a silane compound with a functional group. The function of the additive (C) is to improve the adhesion of the liquid crystal alignment film to the surface of the substrate. Additives (C) can be used alone or in combination of plural kinds.

前述之環氧化合物可包含但不限於乙二醇二環氧丙基醚、聚乙二醇二環氧丙基醚、丙二醇二環氧丙基醚、三丙二醇二環氧丙基醚、聚丙二醇二環氧丙基醚、新戊二醇二環氧丙基醚、1,6-己二醇二環氧丙基醚、丙三醇二環氧丙 基醚、2,2-二溴新戊二醇二環氧丙基醚、1,3,5,6-四環氧丙基-2,4-己二醇、N,N,N',N'-四環氧丙基-間-二甲苯二胺、1,3-雙(N,N-二環氧丙基胺基甲基)環己烷、N,N,N',N'-四環氧丙基-4,4'-二胺基二苯基甲烷、3-(N-烯丙基-N-環氧丙基)胺基丙基三甲氧基矽烷、3-(N,N-二環氧丙基)胺基丙基三甲氧基矽烷等。 The aforementioned epoxy compounds may include, but are not limited to, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, and polypropylene glycol Diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl Glycol Diglycidyl Ether, 1,3,5,6-Tetraglycidyl-2,4-Hexanediol, N,N,N',N'-Tetraglycidyl-M-Di Toluene diamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane, N,N,N',N'-tetraepoxypropyl-4,4'-di Amino diphenylmethane, 3-(N-allyl-N-glycidyl)aminopropyl trimethoxysilane, 3-(N,N-diglycidyl)aminopropyl trimethyl Oxysilane, etc.

基於聚合物(A)的使用量為100重量份,環氧化合物的使用量一般為40重量份以下,且較佳為0.1重量份至30重量份。 Based on the usage amount of the polymer (A) being 100 parts by weight, the usage amount of the epoxy compound is generally 40 parts by weight or less, and preferably 0.1 to 30 parts by weight.

上述具有官能性基團之矽烷化合物可包含但不限於3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷(3-ureidopropyltrimethoxysilane)、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙三胺、N-三甲氧基矽烷基丙基三伸乙三胺、10-三甲氧基矽烷基-1,4,7-三吖癸烷、10-三乙氧基矽烷基-1,4,7-三吖癸烷、9-三甲氧基矽烷基-3,6-二吖壬基醋酸酯、9-三乙氧基矽烷基-3,6-二吖壬基醋酸酯、N-苯甲基-3-胺基丙基三甲氧基矽烷、N-苯甲基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙 基三乙氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三甲氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三乙氧基矽烷等。 The above-mentioned silane compounds with functional groups may include, but are not limited to, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2- Aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyl 3-ureidopropyltrimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyltrimethoxysilane Triethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyl trimethylenetriamine, N-trimethoxysilylpropyl trimethylene Triamine, 10-trimethoxysilyl-1,4,7-triazedane, 10-triethoxysilyl-1,4,7-triazedane, 9-trimethoxysilyl- 3,6-Diazinonyl acetate, 9-triethoxysilyl-3,6-diazenonyl acetate, N-benzyl-3-aminopropyltrimethoxysilane, N- Benzyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltriethoxysilane, N -Bis(oxyethylene)-3-aminopropyltrimethoxysilane, N-bis(oxyethylene)-3-aminopropyltriethoxysilane, etc.

基於聚合物(A)的使用量為100重量份,矽烷化合物的使用量一般為10重量份以下,且較佳為0.5重量份至10重量份。 Based on the usage amount of the polymer (A) being 100 parts by weight, the usage amount of the silane compound is generally 10 parts by weight or less, and preferably 0.5 to 10 parts by weight.

基於聚合物(A)的使用量為100重量份,添加劑(C)的使用量一般可為50重量份以下,且較佳為0.1重量份至30重量份。 Based on the usage amount of the polymer (A) being 100 parts by weight, the usage amount of the additive (C) may generally be 50 parts by weight or less, and preferably 0.1 to 30 parts by weight.

液晶配向劑之製備方法Method for preparing liquid crystal alignment agent

本發明之液晶配向劑之製備方法並無特別之限制,可採用一般之混合方法,如先將四羧酸二酐化合物(a)及二胺化合物(b)混合均勻,以反應形成一聚合物(A)。接著,將聚合物(A)於溫度為0℃至200℃的條件下加入溶劑(B),並可選擇性地加入添加劑(C),以攪拌裝置持續攪拌至溶解即可。較佳地,於20℃至60℃的溫度下,將溶劑(B)添加至聚合物組成物中。 The preparation method of the liquid crystal alignment agent of the present invention is not particularly limited, and general mixing methods can be used, such as first mixing the tetracarboxylic dianhydride compound (a) and the diamine compound (b) uniformly to react to form a polymer (A). Next, the polymer (A) is added to the solvent (B) at a temperature of 0°C to 200°C, and optionally the additive (C) is added, and the stirring device is used to continue stirring until it is dissolved. Preferably, the solvent (B) is added to the polymer composition at a temperature of 20°C to 60°C.

一般而言,於25℃時,本發明之液晶配向劑之黏度可為10cps至90cps,較佳可為15cps至80cps,且更佳為20cps至70cps。 Generally speaking, at 25° C., the viscosity of the liquid crystal alignment agent of the present invention can be 10 cps to 90 cps, preferably 15 cps to 80 cps, and more preferably 20 cps to 70 cps.

液晶配向膜之製備方法Method for preparing liquid crystal alignment film

本發明亦提供一種液晶配向膜,其由前述之液晶配向劑所製造。 The present invention also provides a liquid crystal alignment film, which is manufactured from the aforementioned liquid crystal alignment agent.

較佳地,液晶配向膜之製備方式包含:將上述之液晶配向劑利用輥塗佈法、旋轉塗佈法、印刷法、噴墨法(ink-jet)等方法,塗佈在一基材之表面上,形成一預塗層,接著將預塗層經過預先加熱處理(pre-bake treatment)、後加熱處理(post-bake treatment)及配向處理(alignment treatment),即可製得本發明之液晶配向膜。 Preferably, the preparation method of the liquid crystal alignment film includes: applying the above-mentioned liquid crystal alignment agent to a substrate by roll coating, spin coating, printing, ink-jet, etc. On the surface, a pre-coating layer is formed, and then the pre-coating layer is subjected to pre-bake treatment, post-bake treatment and alignment treatment to obtain the liquid crystal of the present invention Alignment film.

所述預先加熱處理之目的在於使預塗層中之有機溶劑揮發。較佳地,預先加熱處理之操作溫度範圍為30℃至120℃,更佳地為40℃至110℃,又更佳地為50℃至100℃。 The purpose of the preheating treatment is to volatilize the organic solvent in the precoat. Preferably, the operating temperature range of the pre-heating treatment is 30°C to 120°C, more preferably 40°C to 110°C, and still more preferably 50°C to 100°C.

上述之配向處理並無特別之限制,其可採用尼龍、人造絲、棉類等纖維所做成之布料纏繞在滾筒上,以一定方向磨擦進行配向。上述配向處理為本技術領域者所周知,因此不再多加贅述。 The above-mentioned alignment treatment is not particularly limited. It can be made of nylon, rayon, cotton and other fibers, wound on the drum and rubbed in a certain direction for alignment. The above-mentioned alignment processing is well known to those skilled in the art, so it will not be repeated.

後加熱處理步驟目之在於使預塗層中之聚合物再進一步進行脫水閉環(醯亞胺化)反應。較佳地,後加熱處理之操作溫度範圍為150℃至300℃,更佳地為180℃至280℃,又更佳地為200℃至250℃。 The purpose of the post-heating treatment step is to make the polymer in the pre-coating layer undergo further dehydration and ring-closure (imidization) reaction. Preferably, the operating temperature range of the post-heating treatment is 150°C to 300°C, more preferably 180°C to 280°C, and more preferably 200°C to 250°C.

液晶顯示元件之製備方法Method for preparing liquid crystal display element

本發明又提供一種液晶顯示元件,其包含前述之液晶配向膜。 The present invention also provides a liquid crystal display element, which includes the aforementioned liquid crystal alignment film.

液晶顯示元件之製備方式為本技術領域者所周知,因此,以下僅簡單地進行陳述。 The preparation method of the liquid crystal display element is well-known in the art, therefore, the following is only briefly described.

請參閱圖1,其係繪示根據本發明一實施例之液晶顯示元件的側視圖。本發明液晶顯示元件100之較佳實施例包含第一單元110、第二單元120及液晶單元130,其中第二單元120與第一單元110間隔相對,且液晶單元130設置在第一單元110與第二單元120之間。 Please refer to FIG. 1, which shows a side view of a liquid crystal display device according to an embodiment of the present invention. A preferred embodiment of the liquid crystal display element 100 of the present invention includes a first cell 110, a second cell 120, and a liquid crystal cell 130. The second cell 120 is spaced apart from the first cell 110, and the liquid crystal cell 130 is disposed between the first cell 110 and the liquid crystal cell 130. Between the second unit 120.

第一單元110包括第一基板112、電極114及第一液晶配向膜116,其中電極114以櫛齒型圖案化的方式形成於第一基板112之表面,且第一液晶配向膜116形成在電極114之表面。 The first unit 110 includes a first substrate 112, an electrode 114, and a first liquid crystal alignment film 116. The electrode 114 is formed on the surface of the first substrate 112 in a comb-tooth pattern, and the first liquid crystal alignment film 116 is formed on the electrode. The surface of 114.

第二單元120包括第二基板122及第二液晶配向膜126,其中第二液晶配向膜126形成在第二基板122的表面。 The second unit 120 includes a second substrate 122 and a second liquid crystal alignment film 126, wherein the second liquid crystal alignment film 126 is formed on the surface of the second substrate 122.

第一基板112與第二基板122是選自於透明材料等。其中,透明材料可包含但不限於用於液晶顯示裝置的無鹼玻璃、鈉鈣玻璃、硬質玻璃(派勒斯玻璃)、石英玻璃、聚乙烯對苯二甲酸酯、聚丁烯對苯二甲酸酯、聚醚碸、聚碳酸酯等。電極114的材質是擇自於氧化錫(SnO2)、氧化銦-氧化錫(In2O3-SnO2)等的透明電極;或鉻等金屬電極。 The first substrate 112 and the second substrate 122 are selected from transparent materials and the like. Among them, the transparent material may include, but is not limited to, alkali-free glass, soda lime glass, hard glass (Pyles glass), quartz glass, polyethylene terephthalate, and polybutylene terephthalate used in liquid crystal display devices. Formate, polyether block, polycarbonate, etc. The material of the electrode 114 is a transparent electrode selected from tin oxide (SnO 2 ), indium oxide-tin oxide (In 2 O 3 -SnO 2 ), etc.; or a metal electrode such as chromium.

第一液晶配向膜116及第二液晶配向膜126分別為上述之液晶配向膜,其作用在於使液晶單元130形成預傾角,且液晶單元130可被電極114產生的平行電場驅動。 The first liquid crystal alignment film 116 and the second liquid crystal alignment film 126 are the above-mentioned liquid crystal alignment films respectively, and their function is to make the liquid crystal cell 130 form a pretilt angle, and the liquid crystal cell 130 can be driven by the parallel electric field generated by the electrode 114.

液晶單元130所使用的液晶可為單獨一種液晶材料或混合複數種液晶材料。液晶可包含但不限於二胺基苯類液晶、噠嗪(pyridazine)類液晶、希夫氏鹼(shiff base) 類液晶、氧化偶氮基(azoxy)類液晶、苯基環己烷類液晶、聯苯(biphenyl)類液晶、苯基環己烷(phenylcyclohexane)類液晶、酯(ester)類液晶、三聯苯(terphenyl)、聯苯環己烷(biphenylcyclohexane)類液晶、嘧啶(pyrimidine)類液晶、二氧六環(dioxane)類液晶、雙環辛烷(bicyclooctane)類液晶、立方烷(cubane)類液晶等,且可視需求再添加如氯化膽固醇(cholesteryl chloride)、膽固醇壬酸酯(cholesteryl nonanoate)、膽固醇碳酸酯(cholesteryl carbonate)等的膽固醇型液晶,或是商品名為「C-15」、「CB-15」(默克公司製造)的對掌(chiral)劑等,或者對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂酸酯等強誘電性(ferroelectric)類液晶。 The liquid crystal used in the liquid crystal unit 130 may be a single liquid crystal material or a mixture of multiple liquid crystal materials. The liquid crystals may include, but are not limited to, diaminobenzene-based liquid crystals, pyridazine-based liquid crystals, shiff base-based liquid crystals, azoxy-based liquid crystals, phenylcyclohexane-based liquid crystals, Biphenyl liquid crystal, phenylcyclohexane liquid crystal, ester liquid crystal, terphenyl, biphenylcyclohexane liquid crystal, pyrimidine liquid crystal, Dioxane type liquid crystal, bicyclooctane type liquid crystal, cubane type liquid crystal, etc., and can be added as required, such as cholesterol chloride and cholesterol nonanoate , Cholesterol-based liquid crystals such as cholesterol carbonate, or chiral agents with the trade names "C-15" and "CB-15" (manufactured by Merck), or decyloxy Strong ferroelectric liquid crystals such as benzyl-p-amino-2-methylbutyl cinnamate.

本發明的液晶配向劑所製作之液晶顯示元件適用於各式向列液晶,如TN、STN、TFT、VA、IPS等之液晶顯示元件。此外,根據所選擇的液晶,亦可使用於強誘電性或反強誘電性等不同的液晶顯示元件。上述液晶顯示元件中,特別適用於IPS型之液晶顯示元件。 The liquid crystal display element produced by the liquid crystal alignment agent of the present invention is suitable for various types of nematic liquid crystals, such as liquid crystal display elements such as TN, STN, TFT, VA, and IPS. In addition, depending on the selected liquid crystal, it can also be used for liquid crystal display elements with different strong dielectric properties or anti-strong dielectric properties. Among the above-mentioned liquid crystal display elements, it is particularly suitable for IPS type liquid crystal display elements.

以下利用數個實施方式以說明本發明之應用,然其並非用以限定本發明,本發明技術領域中具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾。 The following uses several embodiments to illustrate the application of the present invention, but they are not intended to limit the present invention. Those with ordinary knowledge in the technical field of the present invention can make various changes and modifications without departing from the spirit and scope of the present invention. Retouch.

100‧‧‧液晶顯示元件 100‧‧‧LCD display element

110‧‧‧第一單元 110‧‧‧Unit 1

112‧‧‧第一基板 112‧‧‧First substrate

114‧‧‧電極 114‧‧‧electrode

116‧‧‧第一液晶配向膜 116‧‧‧The first liquid crystal alignment film

120‧‧‧第二單元 120‧‧‧Unit 2

122‧‧‧第二基板 122‧‧‧Second substrate

126‧‧‧第二液晶配向膜 126‧‧‧Second liquid crystal alignment film

130‧‧‧液晶單元 130‧‧‧LCD unit

為了對本發明之實施例及其優點有更完整之理解,現請參照以上之說明並配合相應之圖式。必須強調的是,各種特徵並非依比例描繪且僅係為了圖解目的。相關圖式內容說明如下:〔圖1〕係繪示根據本發明一實施例之液晶顯示元件的側視圖。 In order to have a more complete understanding of the embodiments of the present invention and its advantages, please refer to the above description and cooperate with the corresponding drawings. It must be emphasized that the various features are not drawn to scale and are for illustration purposes only. The contents of the related drawings are described as follows: [FIG. 1] shows a side view of a liquid crystal display device according to an embodiment of the present invention.

製備聚合物(A)Preparation of polymer (A)

以下係根據第1表製備合成例A-1-1至A-1-20與A-2-1至A-2-4比較及合成例A'-1-1至A'-1-4與A'-2-1至A'-2-2之聚合物(A)。 The following is a comparison of synthesis examples A-1-1 to A-1-20 and A-2-1 to A-2-4 and synthesis examples A'-1-1 to A'-1-4 according to Table 1 A'-2-1 to A'-2-2 polymer (A).

合成例A-1-1Synthesis Example A-1-1

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入0.541克(0.005莫耳)的對-二胺苯(b-3-1)、8.922克(0.045莫耳)的4,4'-二胺基二苯基甲烷(b-3-2)及80克的N-甲基-2-吡咯烷酮(以下簡稱NMP),並於室溫下攪拌至溶解。接著,加入1.815克(0.0025莫耳)的如式(I-5)所示之四羧酸二酐化合物(a-1-1)、10.361克(0.0475莫耳)的苯均四羧酸二酐(a-2-1)及20克的NMP,並於室溫下反應2小時。反應結束後,將反應溶液倒入1500毫升的水中,以析出聚合物,過濾所得之聚合物,並以甲醇重複進行清洗及過濾之步驟三次。 之後,將產物置入真空烘箱中,並以溫度60℃進行乾燥,即可製得合成例A-1-1之聚合物(A-1-1)。 A four-necked conical flask with a volume of 500 ml is equipped with a nitrogen inlet, a stirrer, a condenser and a thermometer, and nitrogen is introduced. Then, 0.541 g (0.005 mol) of p-diaminobenzene (b-3-1), 8.922 g (0.045 mol) of 4,4'-diaminodiphenylmethane (b-3-2 ) And 80 grams of N-methyl-2-pyrrolidone (hereinafter referred to as NMP), and stir at room temperature until dissolved. Then, 1.815 g (0.0025 mol) of the tetracarboxylic dianhydride compound (a-1-1) represented by formula (I-5) and 10.361 g (0.0475 mol) of pyromellitic dianhydride were added (a-2-1) and 20 grams of NMP, and react at room temperature for 2 hours. After the reaction, the reaction solution was poured into 1500 ml of water to precipitate the polymer, the obtained polymer was filtered, and the steps of washing and filtering were repeated three times with methanol. After that, the product was placed in a vacuum oven and dried at a temperature of 60° C. to obtain the polymer (A-1-1) of Synthesis Example A-1-1.

合成例A-1-2至A-1-20及比較合成例A'-1-1至A'-1-4Synthesis Examples A-1-2 to A-1-20 and Comparative Synthesis Examples A'-1-1 to A'-1-4

合成例A-1-2至A-1-20及比較合成例A'-1-1至A'-1-4係使用與合成例A-1-1之聚合物的製作方法相同之製備方法,不同之處在於合成例A-1-2至A-1-20及比較合成例A'-1-1至A'-1-4係改變聚合物中原料的種類與使用量,其配方如第1表所示,此處不另贅述。 Synthesis Examples A-1-2 to A-1-20 and Comparative Synthesis Examples A'-1-1 to A'-1-4 use the same preparation method as the preparation method of the polymer of Synthesis Example A-1-1 , The difference is that Synthesis Examples A-1-2 to A-1-20 and Comparative Synthesis Examples A'-1-1 to A'-1-4 are based on changing the type and amount of raw materials in the polymer, and the formula is as As shown in Table 1, it will not be repeated here.

合成例A-2-1Synthesis Example A-2-1

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、加熱器、冷凝管及溫度計,並導入氮氣。然後,加入0.541克(0.005莫耳)的對-二胺苯(b-3-1)、8.922克(0.045莫耳)的4,4'-二胺基二苯基甲烷(b-3-2)及80克的NMP,並於室溫下攪拌至溶解。接著,加入1.815克(0.0025莫耳)的如式(I-5)所示之四羧酸二酐化合物(a-1-1)、10.361克(0.0475莫耳)的苯均四羧酸二酐(a-2-1)及20克的NMP。室溫下反應6小時後,加入97克的NMP、2.55克的醋酸酐及19.75克的吡啶,升溫至60℃,且持續攪拌2小時,以進行醯亞胺化反應。反應結束後,將反應溶液倒入1500毫升的水中,以析出聚合物,過濾所得之聚合物,並以甲醇重複進行清洗及過濾之步驟三次。之後,將產物置入真空烘箱中,並以溫度60℃進行乾燥,即可製得合成例A-2-1之聚合物(A-2-1)。 A four-necked conical flask with a volume of 500 ml is equipped with a nitrogen inlet, agitator, heater, condenser and thermometer, and nitrogen is introduced. Then, 0.541 g (0.005 mol) of p-diaminobenzene (b-3-1), 8.922 g (0.045 mol) of 4,4'-diaminodiphenylmethane (b-3-2 ) And 80 grams of NMP, and stir at room temperature until dissolved. Then, 1.815 g (0.0025 mol) of the tetracarboxylic dianhydride compound (a-1-1) represented by formula (I-5) and 10.361 g (0.0475 mol) of pyromellitic dianhydride were added (a-2-1) and 20 grams of NMP. After reacting at room temperature for 6 hours, 97 g of NMP, 2.55 g of acetic anhydride and 19.75 g of pyridine were added, the temperature was raised to 60° C., and stirring was continued for 2 hours to proceed the imidization reaction. After the reaction, the reaction solution was poured into 1500 ml of water to precipitate the polymer, the obtained polymer was filtered, and the steps of washing and filtering were repeated three times with methanol. After that, the product was placed in a vacuum oven and dried at a temperature of 60° C. to obtain the polymer (A-2-1) of Synthesis Example A-2-1.

合成例A-2-2至A-2-4及比較合成例A'-2-1至A'-2-2Synthesis Examples A-2-2 to A-2-4 and Comparative Synthesis Examples A'-2-1 to A'-2-2

合成例A-2-2至A-2-4及比較合成例A'-2-1至A'-2-2係使用與合成例A-2-1之聚合物的製作方法相同之製備方法,不同之處在於合成例A-2-2至A-2-4及比較合成例A'-2-1至A'-2-2係改變聚合物中原料的種類與使用量,其配方如第1表所示,此處不另贅述。 Synthesis Examples A-2-2 to A-2-4 and Comparative Synthesis Examples A'-2-1 to A'-2-2 use the same preparation method as the preparation method of the polymer of Synthesis Example A-2-1 , The difference is that Synthesis Examples A-2-2 to A-2-4 and Comparative Synthesis Examples A'-2-1 to A'-2-2 are based on changing the types and usage of the raw materials in the polymer. The formula is as follows As shown in Table 1, it will not be repeated here.

製備液晶配向劑Preparation of liquid crystal alignment agent

以下係根據第2與3表製備實施例1至24及比較例1至8之液晶配向劑。 The following is the preparation of liquid crystal alignment agents of Examples 1 to 24 and Comparative Examples 1 to 8 according to Tables 2 and 3.

實施例1Example 1

將100重量份之前述合成例A-1-1所製得之聚合物(A-1-1)加至800重量份之N-甲基-2-吡咯烷酮(以下簡稱為B-1)中,並於室溫下,以攪拌裝置持續攪拌至溶解,即可製得實施例1之液晶配向劑。所得之液晶配向劑以下列之評價方式進行評價,其結果如第2表所示,其中黏度與楊氏模量之檢測方法容後再述。 100 parts by weight of the polymer (A-1-1) prepared in the aforementioned synthesis example A-1-1 was added to 800 parts by weight of N-methyl-2-pyrrolidone (hereinafter referred to as B-1), The liquid crystal alignment agent of Example 1 can be prepared by continuously stirring with a stirring device at room temperature to dissolve. The obtained liquid crystal alignment agent was evaluated by the following evaluation method, and the results are shown in Table 2, in which the detection method of viscosity and Young's modulus will be described later.

實施例2至24及比較例1至8Examples 2 to 24 and Comparative Examples 1 to 8

實施例2至24及比較例1至8係使用與實施例1之液晶配向劑的製作方法相同之製備方法,不同之處在於實施例2至24及比較例1至8係改變液晶配向劑中原料的種類及使用量,其配方及評價結果分別如第2與3表所示。 Examples 2 to 24 and Comparative Examples 1 to 8 used the same preparation method as that of the liquid crystal alignment agent of Example 1, except that Examples 2 to 24 and Comparative Examples 1 to 8 changed the liquid crystal alignment agent The types and amounts of raw materials used, their formulations and evaluation results are shown in Tables 2 and 3, respectively.

評價方式Evaluation method 1.黏度1. Viscosity

於25℃下,使用旋轉黏度計(型號為DV-E,BROOKFIELD製),以100rpm的條件,量測前述實施例1至實施例24及比較例1至比較例8所製得液晶配向劑之黏度(單位為cps)。 At 25°C, using a rotary viscometer (model DV-E, manufactured by BROOKFIELD) at 100 rpm, the liquid crystal alignment agent prepared in the foregoing Examples 1 to 24 and Comparative Examples 1 to 8 was measured Viscosity (in cps).

2.楊氏模量2. Young's modulus

利用旋轉塗佈法方法,將前述實施例1至實施例24及比較例1至比較例8所製得之液晶配向劑塗佈在玻璃基板上,以形成塗佈層。接著,將玻璃基板放置在加熱板上,並以溫度為80℃、時間為2分鐘的條件進行預烤處理。接著,在循環烘箱中,以溫度為235℃、時間為15分鐘的條件進行後烤處理。再經過配向處理後,可製得厚度100nm之液晶配向膜。然後,使用奈米壓痕試驗機(NanoIndenter,型號:MTS NanoIndenter G200,Agilent公司製)量測所製得液晶配向膜之楊氏模量(E,單位為GPa)。其中,奈米壓痕試驗機之探針是使用三角錐形鑽石,並於測定頻率為45MHz,押入深度為20nm,且測定溫度為23℃之條件下進行量測。所測得之楊氏模量係以下述基準進行評價: Using the spin coating method, the liquid crystal alignment agents prepared in the foregoing Examples 1 to 24 and Comparative Examples 1 to 8 were coated on the glass substrate to form a coating layer. Next, the glass substrate was placed on a hot plate, and a pre-baking treatment was performed under the conditions of a temperature of 80°C and a time of 2 minutes. Next, in a circulating oven, a post-bake treatment was performed under the conditions of a temperature of 235°C and a time of 15 minutes. After the alignment treatment, a liquid crystal alignment film with a thickness of 100 nm can be prepared. Then, a nanoindenter (NanoIndenter, model: MTS NanoIndenter G200, manufactured by Agilent) was used to measure the Young's modulus (E, unit of GPa) of the prepared liquid crystal alignment film. Among them, the probe of the nanoindentation tester uses triangular pyramidal diamonds, and the measurement is performed under the conditions of a measurement frequency of 45MHz, a penetration depth of 20nm, and a measurement temperature of 23°C. The measured Young's modulus is evaluated based on the following criteria:

◎:E≧8GPa。 ◎: E≧8GPa.

○:8GPa>E≧6GPa。 ○: 8GPa>E≧6GPa.

△:6GPa>E≧4GPa。 △: 6GPa>E≧4GPa.

×:4GPa>E。 ×: 4GPa>E.

其中,當液晶配向膜之楊氏模量的評價結果為◎時,此液晶配向膜所製得之液晶顯示元件沒有任何碎亮點產生;當液晶配向膜之楊氏模量的評價結果為○時,此液晶配向膜所 製得之液晶顯示元件僅出現些許碎亮點產生;當液晶配向膜之楊氏模量的評價結果為△或×時,此液晶配向膜所製得之液晶顯示元件具有大量碎亮點產生,且隨著楊氏模量下降,碎亮點產生之數量越多。 Wherein, when the evaluation result of the Young's modulus of the liquid crystal alignment film is ⊚, the liquid crystal display element prepared by the liquid crystal alignment film does not have any broken bright spots; when the evaluation result of the Young's modulus of the liquid crystal alignment film is ○ , The liquid crystal display element made of this liquid crystal alignment film only has a few broken bright spots; when the evaluation result of the Young's modulus of the liquid crystal alignment film is △ or ×, the liquid crystal display element made of this liquid crystal alignment film has a lot of Broken bright spots are generated, and as the Young's modulus decreases, the number of broken bright spots is increased.

由第2與3表之結果可知,當本發明之液晶配向劑不包含如式(I)所示之四羧酸二酐化合物(a-1)時,所製得液晶配向膜之楊氏模量過低,而使得含有該液晶配向膜之液晶顯示元件具有大量碎亮點產生之缺陷。 From the results in Tables 2 and 3, it can be seen that when the liquid crystal alignment agent of the present invention does not contain the tetracarboxylic dianhydride compound (a-1) represented by formula (I), the Young's mode of the liquid crystal alignment film produced The amount is too low, and the liquid crystal display element containing the liquid crystal alignment film has a large number of defects caused by broken bright spots.

當如式(I)所示之四羧酸二酐化合物(a-1)中的Z代表-CONH-或-NHCO-時,所製得之液晶配向膜具有較高楊氏模量,而可進一步改善液晶顯示元件之碎亮點缺陷。 When Z in the tetracarboxylic dianhydride compound (a-1) represented by formula (I) represents -CONH- or -NHCO-, the resulting liquid crystal alignment film has a higher Young's modulus, and can Further improve the broken bright spots of liquid crystal display elements.

其次,若聚合物(A)之二胺化合物(b)包含如式(II)所示之二胺化合物(b-1)時,此液晶配向劑所製得之液晶配向膜具有較高楊氏模量,而可進一步改善液晶顯示元件之碎亮點缺陷。 Secondly, if the diamine compound (b) of the polymer (A) contains the diamine compound (b-1) represented by the formula (II), the liquid crystal alignment film prepared by the liquid crystal alignment agent has a higher Young’s Modulus, and can further improve the broken bright spots of liquid crystal display elements.

再者,若聚合物(A)之二胺化合物(b)包含如式(III)所示之二胺化合物(b-2)時,此液晶配向劑所製得之液晶配向膜具有較高楊氏模量,而可進一步改善液晶顯示元件之碎亮點缺陷。 Furthermore, if the diamine compound (b) of the polymer (A) contains the diamine compound (b-2) represented by the formula (III), the liquid crystal alignment film prepared by the liquid crystal alignment agent has a higher The modulus of the liquid crystal display element can be further improved.

需補充的是,本發明雖以特定的化合物、組成、反應條件、製程、分析方法或特定儀器作為例示,說明本發明之液晶配向劑、液晶配向膜及液晶顯示元件,惟本發明所屬技術領域中任何具有通常知識者可知,本發明並不限於 此,在不脫離本發明之精神和範圍內,本發明之液晶配向劑、液晶配向膜及液晶顯示元件亦可使用其他的化合物、組成、反應條件、製程、分析方法或儀器進行。 It should be added that although the present invention uses specific compounds, compositions, reaction conditions, manufacturing processes, analytical methods or specific instruments as examples to illustrate the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element of the present invention, the technical field of the present invention Anyone with ordinary knowledge in the invention can know that the present invention is not limited to this. Without departing from the spirit and scope of the present invention, the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element of the present invention can also use other compounds, compositions, and reactions. Conditions, processes, analytical methods or instrumentation.

雖然本發明已以實施方式揭露如上,然其並非用以限定本發明,在本發明所屬技術領域中任何具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 Although the present invention has been disclosed in the above embodiments, it is not intended to limit the present invention. Anyone with ordinary knowledge in the technical field of the present invention can make various changes and modifications without departing from the spirit and scope of the present invention. Retouching, therefore, the scope of protection of the present invention shall be subject to the scope of the attached patent application.

Figure 106122049-A0101-12-0047-90
Figure 106122049-A0101-12-0047-90

Figure 106122049-A0101-12-0048-91
Figure 106122049-A0101-12-0048-91

Figure 106122049-A0101-12-0049-92
Figure 106122049-A0101-12-0049-92

Claims (12)

一種液晶配向劑,包含:一聚合物(A),由四羧酸二酐化合物(a)及二胺化合物(b)經反應而獲得,其中該四羧酸二酐化合物(a)包含如下式(I)所示之四羧酸二酐化合物(a-1):
Figure 106122049-A0101-13-0001-93
於式(I)中,該R 1、該R 2、該R 3、該R 4、該R 5及該R 6分別獨立地選自於由鹵素原子、經取代或不取代之烷基、經取代或不取代之烷氧基及經取代或不取代之芳香基所組成之一族群的至少一種;該Z分別獨立地代表-CONH-、-NHCO-、-NHCO 2-、-OCONH-或-NHCONH-;該h、該i、該j及該k分別獨立地代表0至4之整數;該m及該n分別獨立地代表0至3之整數;以及一溶劑(B),且其中於25℃時,該液晶配向劑之一黏度為10cps至90cps。
A liquid crystal alignment agent comprising: a polymer (A) obtained by reacting a tetracarboxylic dianhydride compound (a) and a diamine compound (b), wherein the tetracarboxylic dianhydride compound (a) comprises the following formula Tetracarboxylic dianhydride compound (a-1) shown in (I):
Figure 106122049-A0101-13-0001-93
In the formula (I), the R 1 , the R 2 , the R 3 , the R 4 , the R 5 and the R 6 are each independently selected from halogen atoms, substituted or unsubstituted alkyl groups, and At least one of a group consisting of a substituted or unsubstituted alkoxy group and a substituted or unsubstituted aromatic group; the Z each independently represents -CONH-, -NHCO-, -NHCO 2 -, -OCONH- or- NHCONH-; the h, the i, the j, and the k each independently represent an integer from 0 to 4; the m and the n each independently represent an integer from 0 to 3; and a solvent (B), where 25 At °C, one of the liquid crystal alignment agents has a viscosity of 10 cps to 90 cps.
如申請專利範圍第1項所述之液晶配向劑,其中該Z代表-CONH-或-NHCO-。 The liquid crystal alignment agent described in item 1 of the scope of patent application, wherein the Z represents -CONH- or -NHCO-. 如申請專利範圍第1項所述之液晶配向劑,其中該二胺化合物(b)包含如式(II)所示之二胺化合物(b-1):
Figure 106122049-A0101-13-0002-94
於式(II)中,該W 1代表被3級氮原子所取代且碳數為4至6之伸環烷基,且該W 2代表碳數為1至5之伸烷基。
The liquid crystal alignment agent described in item 1 of the scope of patent application, wherein the diamine compound (b) comprises a diamine compound (b-1) represented by formula (II):
Figure 106122049-A0101-13-0002-94
In the formula (II), the W 1 represents a cycloalkylene group with a carbon number of 4 to 6 substituted by a tertiary nitrogen atom, and the W 2 represents an alkylene group with a carbon number of 1 to 5.
如申請專利範圍第1項所述之液晶配向劑,其中該二胺化合物(b)包含如式(III)所示之二胺化合物(b-2):
Figure 106122049-A0101-13-0002-95
於式(III)中,該y代表1至12之整數。
The liquid crystal alignment agent described in item 1 of the scope of patent application, wherein the diamine compound (b) comprises a diamine compound (b-2) represented by formula (III):
Figure 106122049-A0101-13-0002-95
In formula (III), the y represents an integer of 1-12.
如申請專利範圍第1項所述之液晶配向劑,其中該液晶配向劑之該黏度為15cps至80cps。 The liquid crystal alignment agent described in item 1 of the scope of patent application, wherein the viscosity of the liquid crystal alignment agent is 15 cps to 80 cps. 如申請專利範圍第1項所述之液晶配向劑,其中該液晶配向劑之該黏度為20cps至70cps。 The liquid crystal alignment agent described in item 1 of the scope of patent application, wherein the viscosity of the liquid crystal alignment agent is 20 cps to 70 cps. 如申請專利範圍第1項所述之液晶配向劑,其中基於該聚合物(A)之總使用量為100重量份,該溶劑(B)之使用量為500重量份至3000重量份。 The liquid crystal alignment agent described in item 1 of the scope of patent application, wherein the total usage amount based on the polymer (A) is 100 parts by weight, and the usage amount of the solvent (B) is 500 parts by weight to 3000 parts by weight. 如申請專利範圍第1項所述之液晶配向劑,其中基於該四羧酸二酐化合物(a)之總使用量為100莫耳,該四羧酸二酐化合物(a-1)之使用量為5莫耳至60莫耳。 The liquid crystal alignment agent described in item 1 of the scope of patent application, wherein based on the total usage amount of the tetracarboxylic dianhydride compound (a) is 100 mol, the usage amount of the tetracarboxylic dianhydride compound (a-1) It ranges from 5 mol to 60 mol. 如申請專利範圍第3項所述之液晶配向劑,其中基於該二胺化合物(b)之總使用量為100莫耳,該二胺化合物(b-1)之使用量為3莫耳至45莫耳。 The liquid crystal alignment agent described in item 3 of the scope of patent application, wherein based on the total usage amount of the diamine compound (b) is 100 mol, the usage amount of the diamine compound (b-1) is 3 mol to 45 mol Mol. 如申請專利範圍第4項所述之液晶配向劑,其中基於該二胺化合物(b)之總使用量為100莫耳,該二胺化合物(b-2)之使用量為10莫耳至95莫耳。 The liquid crystal alignment agent described in item 4 of the scope of patent application, wherein based on the total usage amount of the diamine compound (b) is 100 mol, the usage amount of the diamine compound (b-2) is 10 mol to 95 mol Mol. 一種液晶配向膜,包含如申請專利範圍第1至10項中之任一項所述之液晶配向劑。 A liquid crystal alignment film, comprising the liquid crystal alignment agent described in any one of items 1 to 10 in the scope of the patent application. 一種液晶顯示元件,包含如申請專利範圍第11項所述之液晶配向膜。 A liquid crystal display element includes the liquid crystal alignment film as described in item 11 of the scope of patent application.
TW106122049A 2017-06-30 2017-06-30 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element TWI710585B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW106122049A TWI710585B (en) 2017-06-30 2017-06-30 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
CN201810683322.9A CN109207170B (en) 2017-06-30 2018-06-27 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106122049A TWI710585B (en) 2017-06-30 2017-06-30 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Publications (2)

Publication Number Publication Date
TW201905039A TW201905039A (en) 2019-02-01
TWI710585B true TWI710585B (en) 2020-11-21

Family

ID=64989461

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106122049A TWI710585B (en) 2017-06-30 2017-06-30 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Country Status (2)

Country Link
CN (1) CN109207170B (en)
TW (1) TWI710585B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7139956B2 (en) * 2018-10-04 2022-09-21 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, tetracarboxylic dianhydride, polyamic acid and its derivatives
JP7120032B2 (en) * 2019-01-10 2022-08-17 Jnc株式会社 Liquid crystal aligning agent for photo-alignment, liquid crystal alignment film, and liquid crystal display element
CN117229506B (en) * 2023-11-16 2024-03-15 山东华夏神舟新材料有限公司 Polyamic acid, polyimide film and preparation method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI521017B (en) * 2014-02-14 2016-02-11 奇美實業股份有限公司 Liquid crystal alignment composition, liquid crystal alignment film and liquid crystal display device having thereof
CN106255714A (en) * 2014-04-18 2016-12-21 长濑化成株式会社 Resist resin and manufacture method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750641A (en) * 1996-05-23 1998-05-12 Minnesota Mining And Manufacturing Company Polyimide angularity enhancement layer
TW448336B (en) * 1996-07-11 2001-08-01 Nissan Chemical Ind Ltd Alignment treating agent for a liquid crystal cell
JP4485240B2 (en) * 2004-04-09 2010-06-16 富士フイルム株式会社 Polyamic acid and polyimide
JP2005306983A (en) * 2004-04-21 2005-11-04 Fuji Photo Film Co Ltd Optical film and image display device
TWI503610B (en) * 2013-05-03 2015-10-11 Chi Mei Corp Liquid crystal alignment composition, liquid crystal alignment film and liquid crystal display device having thereof
TWI565756B (en) * 2015-03-04 2017-01-11 奇美實業股份有限公司 Composition for liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element having the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI521017B (en) * 2014-02-14 2016-02-11 奇美實業股份有限公司 Liquid crystal alignment composition, liquid crystal alignment film and liquid crystal display device having thereof
CN106255714A (en) * 2014-04-18 2016-12-21 长濑化成株式会社 Resist resin and manufacture method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A *

Also Published As

Publication number Publication date
CN109207170A (en) 2019-01-15
TW201905039A (en) 2019-02-01
CN109207170B (en) 2021-12-10

Similar Documents

Publication Publication Date Title
JP5444690B2 (en) Liquid crystal aligning agent and liquid crystal display element
US8962739B2 (en) Liquid crystal alignment agent, and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent
JP2009037222A (en) Liquid crystal aligning agent and liquid crystal display element
KR20080042014A (en) Liquid crystal aligning agent and liquid crystal display device
TWI710585B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR20090100274A (en) Liquid crystal aligning agent and liquid crystal display device
KR20090101109A (en) Liquid crystal aligning agent and liquid crystal display device
JP2010066577A (en) Liquid crystal orientation agent and liquid crystal display element
CN110499164B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI482801B (en) Liquid crystal alignment composition, liquid crystal alignment film and liquid crystal display element having thereof
JP2009294274A (en) Liquid crystal aligning agent, liquid crystal alignment layer, and liquid crystal display element
JP5067570B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5224034B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5019050B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5019049B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI742094B (en) Method of producing liquid crystal alignment film and liquid crystal display
JP2008102260A (en) Liquid crystal aligning agent and liquid crystal display element
JP4788890B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI649351B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI644945B (en) Liquid crystal alignment agent and uses thereof
KR20080020520A (en) Liquid crystal aligning agent and liquid crystal display
JP2009294281A (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
JP5158351B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP2007047763A (en) Liquid crystal aligning agent and liquid crystal display device
TWI666232B (en) Liquid crystal alignment agent and production method thereof, liquid crystal alignment film and production method thereof, and liquid crystal display element